SLK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O75534 | T761 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | GPKAVAAPRPDRLVNRLKNItLDDAsAPRLMVLRQPRGPDN |
| O75821 | T240 | Sugiyama | EIF3G EIF3S4 | DGAsRRGESMQPNRRADDNAtIRVtNLSEDTRETDLQELFR |
| O95373 | T968 | Sugiyama | IPO7 RANBP7 | IIDDEDNPVDEYQIFKAIFQtIQNRNPVWyQALTHGLNEEQ |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00441 | S103 | Sugiyama | SOD1 | GDLGNVtADKDGVADVsIEDsVIsLsGDHCIIGRTLVVHEK |
| P00441 | S106 | Sugiyama | SOD1 | GNVtADKDGVADVsIEDsVIsLsGDHCIIGRTLVVHEKADD |
| P00441 | S99 | Sugiyama | SOD1 | ERHVGDLGNVtADKDGVADVsIEDsVIsLsGDHCIIGRTLV |
| P00558 | S390 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | IIGGGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPG |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | S390 | Sugiyama | PGK2 PGKB | VIGGGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPG |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07900 | S476 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | RKKLsELLRyytsAsGDEMVsLKDYCTRMKENQKHIyyItG |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | T88 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | sKLDsGKELHINLIPNKQDRtLtIVDtGIGMTKADLINNLG |
| P07900 | T90 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LDsGKELHINLIPNKQDRtLtIVDtGIGMTKADLINNLGtI |
| P07900 | Y465 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IKLGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMK |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | T637 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MGyMMAKKHLEINPDHPIVEtLRQKAEADKNDKAVKDLVVL |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | S54 | Sugiyama | TUBA3C TUBA2 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P0DPH7 | T334 | Sugiyama | TUBA3C TUBA2 | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| P0DPH7 | T41 | Sugiyama | TUBA3C TUBA2 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P10809 | T117 | Sugiyama | HSPD1 HSP60 | LVQDVANNtNEEAGDGtttAtVLARSIAKEGFEKISKGANP |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P15311 | T567 | PSP | EZR VIL2 | RTHNDIIHNENMRQGRDKYKtLRQIRQGNTKQRIDEFEAL_ |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23526 | S183 | Sugiyama | AHCY SAHH | NLyKMMANGILKVPAINVNDsVtKsKFDNLyGCRESLIDGI |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26038 | T558 | PSP | MSN | KTANDMIHAENMRLGRDKYKtLRQIRQGNTKQRIDEFEsM_ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P35241 | T564 | PSP | RDX | KTQNDVLHAENVKAGRDKYKtLRQIRQGNtKQRIDEFEAM_ |
| P35269 | T41 | Sugiyama | GTF2F1 RAP74 | NTTKKyNIMAFNAADKVNFAtWNQARLERDLSNKKIyQEEE |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P37108 | T45 | Sugiyama | SRP14 | sVyItLKKYDGRTKPIPKKGtVEGFEPADNKCLLRATDGKK |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P39019 | T36 | Sugiyama | RPS19 | RALAAFLKKSGKLKVPEWVDtVKLAKHKELAPyDENWFytR |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T304 | Sugiyama | ACTB | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y294 | Sugiyama | ACTB | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62273 | S9 | Sugiyama | RPS29 | ____________MGHQQLyWsHPRKFGQGSRSCRVCSNRHG |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T146 | Sugiyama | RPL8 | LARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANRAVV |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T304 | Sugiyama | ACTG1 ACTG | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y294 | Sugiyama | ACTG1 ACTG | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | S54 | Sugiyama | TUBA1B | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P68363 | T334 | Sugiyama | TUBA1B | ACCLLyRGDVVPKDVNAAIAtIKtKRsIQFVDWCPTGFKVG |
| P68363 | T41 | Sugiyama | TUBA1B | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q01518 | T165 | Sugiyama | CAP1 CAP | AMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVKA |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15293 | T71 | Sugiyama | RCN1 RCN | EDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRI |
| Q16658 | T239 | Sugiyama | FSCN1 FAN1 HSN SNL | GKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALEQs |
| Q16775 | T292 | Sugiyama | HAGH GLO2 HAGH1 | FMRVREKTVQQHAGETDPVttMRAVRREKDQFKMPRD____ |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FG1 | T28 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | SKLDSGKEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLG |
| Q58FG1 | T30 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | LDSGKEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLGTI |
| Q5T1R4 | S1680 | Sugiyama | HIVEP3 KBP1 KIAA1555 KRC ZAS3 | ETYTMATAPHPEAGRLVPsSsRKPRMTEVHLPSLVSPEGQK |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | S54 | Sugiyama | TUBA3E | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q6PEY2 | T334 | Sugiyama | TUBA3E | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q6PEY2 | T41 | Sugiyama | TUBA3E | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | S54 | Sugiyama | TUBA1A TUBA3 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q71U36 | T334 | Sugiyama | TUBA1A TUBA3 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q71U36 | T41 | Sugiyama | TUBA1A TUBA3 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q92688 | T105 | Sugiyama | ANP32B APRIL PHAPI2 | EKLPNLTHLNLsGNKLKDIstLEPLKKLECLKsLDLFNCEV |
| Q99426 | T120 | Sugiyama | TBCB CG22 CKAP1 | DVSRVEKytIsQEAyDQRQDtVRSFLKRsKLGRyNEEERAQ |
| Q99613 | T880 | Sugiyama | EIF3C EIF3S8 | AEKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMR |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | S54 | Sugiyama | TUBA1C TUBA6 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q9BQE3 | T334 | Sugiyama | TUBA1C TUBA6 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q9BQE3 | T41 | Sugiyama | TUBA1C TUBA6 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9H2G2 | S189 | PSP | SLK KIAA0204 STK2 | IKLADFGVsAKNTRtIQRRDsFIGtPYWMAPEVVMCETSKD |
| Q9H2G2 | S340 | Sugiyama | SLK KIAA0204 STK2 | EEDEEEEtENsLPIPAsKRAssDLsIAssEEDKLsQNACIL |
| Q9H2G2 | S341 | Sugiyama | SLK KIAA0204 STK2 | EDEEEEtENsLPIPAsKRAssDLsIAssEEDKLsQNACILE |
| Q9H2G2 | S344 | Sugiyama | SLK KIAA0204 STK2 | EEEtENsLPIPAsKRAssDLsIAssEEDKLsQNACILEsVS |
| Q9H2G2 | S347 | Sugiyama | SLK KIAA0204 STK2 | tENsLPIPAsKRAssDLsIAssEEDKLsQNACILEsVSEKt |
| Q9H2G2 | S362 | Sugiyama | SLK KIAA0204 STK2 | DLsIAssEEDKLsQNACILEsVSEKtERSNsEDKLNSKILN |
| Q9H2G2 | S446 | Sugiyama | SLK KIAA0204 STK2 | KRPKLENLPDTEDQEtVDINsVsEGKENNIMITLETNIEHN |
| Q9H2G2 | S448 | Sugiyama | SLK KIAA0204 STK2 | PKLENLPDTEDQEtVDINsVsEGKENNIMITLETNIEHNLK |
| Q9H2G2 | S518 | Sugiyama | SLK KIAA0204 STK2 | tVDLVSQEtGEKEANIQAVDsEVGLTKEDtQEKLGEDDKTQ |
| Q9H2G2 | S546 | Sugiyama | SLK KIAA0204 STK2 | DtQEKLGEDDKTQKDVIsNtsDVIGtCEAADVAQKVDEDsA |
| Q9H2G2 | S565 | Sugiyama | SLK KIAA0204 STK2 | tsDVIGtCEAADVAQKVDEDsAEDtQsNDGKEVVEVGQKLI |
| Q9H2G2 | S571 | Sugiyama | SLK KIAA0204 STK2 | tCEAADVAQKVDEDsAEDtQsNDGKEVVEVGQKLINKPMVG |
| Q9H2G2 | S818 | Sugiyama | SLK KIAA0204 STK2 | FIVDGVEVSVTtSKIVtDsDsKtEELRFLRRQELRELRFLQ |
| Q9H2G2 | T183 | PSP | SLK KIAA0204 STK2 | FTLDGDIKLADFGVsAKNTRtIQRRDsFIGtPYWMAPEVVM |
| Q9H2G2 | T441 | Sugiyama | SLK KIAA0204 STK2 | ENEREKRPKLENLPDTEDQEtVDINsVsEGKENNIMITLET |
| Q9H2G2 | T527 | Sugiyama | SLK KIAA0204 STK2 | GEKEANIQAVDsEVGLTKEDtQEKLGEDDKTQKDVIsNtsD |
| Q9H2G2 | T676 | Sugiyama | SLK KIAA0204 STK2 | VVADTDQKALGsEVQDASKVtTQIDKEKKEIPVSIKKEPEV |
| Q9H2G2 | T734 | Sugiyama | SLK KIAA0204 STK2 | NINSDSGENKEEIGSLSKTEtILPPESENPKENDNDSGTGS |
| Q9H2G2 | T809 | Sugiyama | SLK KIAA0204 STK2 | KKTLKKTRKFIVDGVEVSVTtSKIVtDsDsKtEELRFLRRQ |
| Q9H2G2 | T814 | Sugiyama | SLK KIAA0204 STK2 | KTRKFIVDGVEVSVTtSKIVtDsDsKtEELRFLRRQELREL |
| Q9H2G2 | T820 | Sugiyama | SLK KIAA0204 STK2 | VDGVEVSVTtSKIVtDsDsKtEELRFLRRQELRELRFLQKE |
| Q9H2K8 | T181 | iPTMNet | TAOK3 DPK JIK KDS MAP3K18 | VKLADFGsAsMAsPANsFVGtPyWMAPEVILAMDEGQYDGK |
| Q9H2K8 | Y183 | iPTMNet | TAOK3 DPK JIK KDS MAP3K18 | LADFGsAsMAsPANsFVGtPyWMAPEVILAMDEGQYDGKVD |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9UBR2 | S78 | Sugiyama | CTSZ | SPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHAST |
| Q9Y597 | T673 | Sugiyama | KCTD3 | sPLLARARRtEsFHSYRDFQtINLNRNVERAVPENGNLGPI |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 2.764357e-07 | 6.558 | 1 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.826849e-05 | 4.738 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.064348e-05 | 4.514 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 3.064348e-05 | 4.514 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.508803e-05 | 4.259 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.987144e-05 | 4.156 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.064857e-05 | 4.151 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.465082e-05 | 4.072 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 9.920847e-05 | 4.003 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.057727e-04 | 3.976 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.715562e-04 | 3.766 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.134674e-04 | 3.671 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.134674e-04 | 3.671 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.035550e-04 | 3.691 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.946189e-04 | 3.711 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.432226e-04 | 3.614 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.010408e-04 | 3.521 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.024528e-04 | 3.519 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.010408e-04 | 3.521 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.071813e-04 | 3.390 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.612031e-04 | 3.336 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.880893e-04 | 3.312 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.855757e-04 | 3.164 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.855757e-04 | 3.164 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 7.161970e-04 | 3.145 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 7.116046e-04 | 3.148 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.728425e-04 | 3.172 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 8.226316e-04 | 3.085 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 8.226316e-04 | 3.085 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.950034e-04 | 3.100 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 8.253507e-04 | 3.083 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.795468e-04 | 3.056 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.093094e-03 | 2.961 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.093094e-03 | 2.961 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.093094e-03 | 2.961 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.093094e-03 | 2.961 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.093094e-03 | 2.961 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.889500e-04 | 3.005 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.136632e-03 | 2.944 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.156091e-03 | 2.937 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.207770e-03 | 2.918 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.370374e-03 | 2.863 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.415107e-03 | 2.849 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.583940e-03 | 2.800 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.564032e-03 | 2.806 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.824313e-03 | 2.739 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.802833e-03 | 2.744 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.853621e-03 | 2.732 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.003202e-03 | 2.698 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.927175e-03 | 2.715 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.977067e-03 | 2.704 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.093815e-03 | 2.679 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.300785e-03 | 2.638 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.300785e-03 | 2.638 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.193463e-03 | 2.659 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.404243e-03 | 2.619 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.404367e-03 | 2.619 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.479514e-03 | 2.606 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.861873e-03 | 2.543 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.879808e-03 | 2.541 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.861873e-03 | 2.543 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.910434e-03 | 2.536 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.363319e-03 | 2.473 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.363319e-03 | 2.473 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.382552e-03 | 2.471 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.233398e-03 | 2.490 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.515689e-03 | 2.454 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.629836e-03 | 2.440 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.270342e-03 | 2.370 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.705944e-03 | 2.327 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.705944e-03 | 2.327 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.705944e-03 | 2.327 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.705944e-03 | 2.327 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.133876e-03 | 2.290 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.864857e-03 | 2.313 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.144460e-03 | 2.289 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.144460e-03 | 2.289 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.864857e-03 | 2.313 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.872823e-03 | 2.231 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.876596e-03 | 2.231 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.977899e-03 | 2.223 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.781646e-03 | 2.169 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.634505e-03 | 2.178 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.781646e-03 | 2.169 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.781646e-03 | 2.169 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.946032e-03 | 2.158 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.977924e-03 | 2.156 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.089520e-03 | 2.149 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.460027e-03 | 2.127 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.947716e-03 | 2.100 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.510308e-03 | 2.124 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.510308e-03 | 2.124 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.004566e-03 | 2.097 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 8.019312e-03 | 2.096 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.591308e-03 | 2.066 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 9.089412e-03 | 2.041 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 9.165611e-03 | 2.038 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 9.327628e-03 | 2.030 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 9.676753e-03 | 2.014 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.017191e-02 | 1.993 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.923101e-03 | 2.003 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.832717e-03 | 2.007 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.050326e-02 | 1.979 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.087204e-02 | 1.964 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.143545e-02 | 1.942 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.199852e-02 | 1.921 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.218201e-02 | 1.914 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.218201e-02 | 1.914 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.226710e-02 | 1.911 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.237440e-02 | 1.907 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.280587e-02 | 1.893 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.288767e-02 | 1.890 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.358519e-02 | 1.867 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.415721e-02 | 1.849 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.428744e-02 | 1.845 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.428744e-02 | 1.845 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.334308e-02 | 1.875 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.387128e-02 | 1.858 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.437164e-02 | 1.842 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.437164e-02 | 1.842 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.303179e-02 | 1.885 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.342826e-02 | 1.872 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.452993e-02 | 1.838 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.551368e-02 | 1.809 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.551368e-02 | 1.809 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.551368e-02 | 1.809 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.551368e-02 | 1.809 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.567233e-02 | 1.805 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.575126e-02 | 1.803 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.588431e-02 | 1.799 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.588431e-02 | 1.799 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.844808e-02 | 1.734 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.849896e-02 | 1.733 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.698419e-02 | 1.770 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.686839e-02 | 1.773 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.834294e-02 | 1.737 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.844808e-02 | 1.734 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.904038e-02 | 1.720 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.943967e-02 | 1.711 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.964123e-02 | 1.707 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.994123e-02 | 1.700 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.138845e-02 | 1.670 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.259347e-02 | 1.646 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.386329e-02 | 1.622 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.468967e-02 | 1.607 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.350162e-02 | 1.629 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.573099e-02 | 1.590 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.455912e-02 | 1.610 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.631832e-02 | 1.580 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.450024e-02 | 1.611 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.573099e-02 | 1.590 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.450024e-02 | 1.611 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 2.573099e-02 | 1.590 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 2.573099e-02 | 1.590 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.350162e-02 | 1.629 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.350162e-02 | 1.629 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.547486e-02 | 1.594 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.663111e-02 | 1.575 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.748666e-02 | 1.561 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.809669e-02 | 1.551 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.810842e-02 | 1.551 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.823311e-02 | 1.549 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.839808e-02 | 1.547 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 3.332289e-02 | 1.477 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.332289e-02 | 1.477 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.332289e-02 | 1.477 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 3.332289e-02 | 1.477 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.957302e-02 | 1.529 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.206369e-02 | 1.494 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.953366e-02 | 1.530 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.262822e-02 | 1.486 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.262822e-02 | 1.486 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.060151e-02 | 1.514 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.262822e-02 | 1.486 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.318809e-02 | 1.479 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.060151e-02 | 1.514 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.332289e-02 | 1.477 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.030222e-02 | 1.519 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.060151e-02 | 1.514 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.909309e-02 | 1.536 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.206369e-02 | 1.494 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.445460e-02 | 1.463 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.514638e-02 | 1.454 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 3.515572e-02 | 1.454 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.515572e-02 | 1.454 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.591758e-02 | 1.445 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.603839e-02 | 1.443 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.603839e-02 | 1.443 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 3.618404e-02 | 1.441 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 4.124131e-02 | 1.385 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 4.059565e-02 | 1.392 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.940409e-02 | 1.404 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.308956e-02 | 1.366 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.225264e-02 | 1.374 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.225264e-02 | 1.374 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.361646e-02 | 1.360 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.940409e-02 | 1.404 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.398868e-02 | 1.357 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.124131e-02 | 1.385 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.055003e-02 | 1.392 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.773490e-02 | 1.423 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.066528e-02 | 1.391 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.059565e-02 | 1.392 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.205906e-02 | 1.376 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.290604e-02 | 1.367 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.059565e-02 | 1.392 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.940409e-02 | 1.404 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.308956e-02 | 1.366 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.116764e-02 | 1.385 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.940409e-02 | 1.404 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.711519e-02 | 1.430 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.711519e-02 | 1.430 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.711519e-02 | 1.430 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.398868e-02 | 1.357 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.499566e-02 | 1.347 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 4.616039e-02 | 1.336 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 4.616039e-02 | 1.336 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 4.616039e-02 | 1.336 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 4.616039e-02 | 1.336 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.782001e-02 | 1.320 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.867701e-02 | 1.313 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.221308e-02 | 1.282 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.267109e-02 | 1.278 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.329803e-02 | 1.273 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.430576e-02 | 1.265 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.430576e-02 | 1.265 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.430576e-02 | 1.265 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.572947e-02 | 1.254 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.572947e-02 | 1.254 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 5.572947e-02 | 1.254 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.572947e-02 | 1.254 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.572947e-02 | 1.254 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.590169e-02 | 1.253 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.590169e-02 | 1.253 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.842356e-02 | 1.165 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.842356e-02 | 1.165 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.240588e-02 | 1.205 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 7.038284e-02 | 1.153 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.942518e-02 | 1.158 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.700318e-02 | 1.174 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.038284e-02 | 1.153 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.038284e-02 | 1.153 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 7.038284e-02 | 1.153 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.700318e-02 | 1.174 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.363425e-02 | 1.133 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.363425e-02 | 1.133 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.363425e-02 | 1.133 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.842356e-02 | 1.165 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.984162e-02 | 1.223 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 7.313758e-02 | 1.136 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.038284e-02 | 1.153 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.218370e-02 | 1.206 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.211582e-02 | 1.142 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.033044e-02 | 1.219 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.241663e-02 | 1.205 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.516004e-02 | 1.186 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.453324e-02 | 1.190 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.313758e-02 | 1.136 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.451612e-02 | 1.128 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 7.451612e-02 | 1.128 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.604779e-02 | 1.119 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.689860e-02 | 1.114 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.822311e-02 | 1.107 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.879305e-02 | 1.104 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 7.879305e-02 | 1.104 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.954667e-02 | 1.099 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 7.980436e-02 | 1.098 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 8.195817e-02 | 1.086 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 8.195817e-02 | 1.086 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 8.195817e-02 | 1.086 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 8.195817e-02 | 1.086 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 8.195817e-02 | 1.086 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.407022e-02 | 1.075 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.407022e-02 | 1.075 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.453396e-02 | 1.073 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 8.460246e-02 | 1.073 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.600794e-02 | 1.065 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 8.622487e-02 | 1.064 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.622487e-02 | 1.064 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.651204e-02 | 1.063 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 8.761787e-02 | 1.057 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.761787e-02 | 1.057 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.761787e-02 | 1.057 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.761787e-02 | 1.057 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 8.902874e-02 | 1.050 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 9.019266e-02 | 1.045 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 9.019266e-02 | 1.045 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 9.019266e-02 | 1.045 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 9.019266e-02 | 1.045 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 9.019266e-02 | 1.045 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 9.019266e-02 | 1.045 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 9.622888e-02 | 1.017 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 9.622888e-02 | 1.017 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 9.622888e-02 | 1.017 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.111391e-01 | 0.954 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 9.683771e-02 | 1.014 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.078087e-01 | 0.967 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.300455e-02 | 1.031 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.022121e-01 | 0.990 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.169136e-01 | 0.932 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.013717e-01 | 0.994 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.064322e-01 | 0.973 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.111391e-01 | 0.954 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.028827e-01 | 0.988 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.028827e-01 | 0.988 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 1.192375e-01 | 0.924 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.202496e-01 | 0.920 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 9.304118e-02 | 1.031 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.111391e-01 | 0.954 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.091188e-01 | 0.962 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.056887e-01 | 0.976 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.221250e-01 | 0.913 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.183832e-02 | 1.037 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.111391e-01 | 0.954 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.163804e-01 | 0.934 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.111391e-01 | 0.954 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.073642e-01 | 0.969 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.199331e-01 | 0.921 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 9.994084e-02 | 1.000 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.111391e-01 | 0.954 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.593095e-02 | 1.018 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 9.622888e-02 | 1.017 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.111391e-01 | 0.954 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.155342e-01 | 0.937 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 1.114632e-01 | 0.953 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.022121e-01 | 0.990 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.683771e-02 | 1.014 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.199183e-01 | 0.921 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 9.316592e-02 | 1.031 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 1.234144e-01 | 0.909 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 1.234144e-01 | 0.909 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.265996e-01 | 0.898 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.265996e-01 | 0.898 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 1.265996e-01 | 0.898 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.266611e-01 | 0.897 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.266611e-01 | 0.897 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.266611e-01 | 0.897 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.266611e-01 | 0.897 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.280671e-01 | 0.893 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.284789e-01 | 0.891 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.287117e-01 | 0.890 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.287117e-01 | 0.890 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.287588e-01 | 0.890 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.293325e-01 | 0.888 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.321948e-01 | 0.879 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 1.321948e-01 | 0.879 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 1.321948e-01 | 0.879 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.321948e-01 | 0.879 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.349999e-01 | 0.870 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.353747e-01 | 0.868 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.354790e-01 | 0.868 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.358152e-01 | 0.867 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.372525e-01 | 0.862 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.399151e-01 | 0.854 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.415475e-01 | 0.849 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.425279e-01 | 0.846 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.425279e-01 | 0.846 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.425279e-01 | 0.846 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.425279e-01 | 0.846 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.460586e-01 | 0.835 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.722603e-01 | 0.764 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.722603e-01 | 0.764 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.722603e-01 | 0.764 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.722603e-01 | 0.764 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.722603e-01 | 0.764 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.722603e-01 | 0.764 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.722603e-01 | 0.764 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.722603e-01 | 0.764 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 1.722603e-01 | 0.764 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.722603e-01 | 0.764 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 1.722603e-01 | 0.764 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.722603e-01 | 0.764 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.722603e-01 | 0.764 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.722603e-01 | 0.764 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.104784e-01 | 0.677 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 2.104784e-01 | 0.677 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.469341e-01 | 0.607 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.469341e-01 | 0.607 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.469341e-01 | 0.607 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.469341e-01 | 0.607 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.469341e-01 | 0.607 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.817085e-01 | 0.550 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.817085e-01 | 0.550 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.588481e-01 | 0.799 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.588481e-01 | 0.799 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.588481e-01 | 0.799 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.754902e-01 | 0.756 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 3.148792e-01 | 0.502 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.148792e-01 | 0.502 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.148792e-01 | 0.502 | 0 | 0 |
| Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS) | R-HSA-5619063 | 3.148792e-01 | 0.502 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.923898e-01 | 0.716 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.923898e-01 | 0.716 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.465200e-01 | 0.460 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.465200e-01 | 0.460 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.465200e-01 | 0.460 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.267299e-01 | 0.644 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.267299e-01 | 0.644 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 2.440665e-01 | 0.612 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.440665e-01 | 0.612 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.440665e-01 | 0.612 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.767014e-01 | 0.424 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.767014e-01 | 0.424 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.767014e-01 | 0.424 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.767014e-01 | 0.424 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.767014e-01 | 0.424 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.767014e-01 | 0.424 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.061205e-01 | 0.686 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.054905e-01 | 0.392 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.054905e-01 | 0.392 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.054905e-01 | 0.392 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.054905e-01 | 0.392 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.962088e-01 | 0.528 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.962088e-01 | 0.528 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.430310e-01 | 0.614 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 3.135079e-01 | 0.504 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.329516e-01 | 0.364 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.329516e-01 | 0.364 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 3.307116e-01 | 0.481 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.477920e-01 | 0.459 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.477920e-01 | 0.459 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.477920e-01 | 0.459 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.647238e-01 | 0.438 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.793026e-01 | 0.746 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.814843e-01 | 0.419 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.980533e-01 | 0.400 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 4.144127e-01 | 0.383 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.264707e-01 | 0.486 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.830353e-01 | 0.417 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.941157e-01 | 0.712 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.397694e-01 | 0.620 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.670396e-01 | 0.777 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.430310e-01 | 0.614 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.477920e-01 | 0.459 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.940085e-01 | 0.404 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.754902e-01 | 0.756 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 3.767014e-01 | 0.424 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 2.681936e-01 | 0.572 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.282933e-01 | 0.484 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.387215e-01 | 0.622 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.817085e-01 | 0.550 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.440665e-01 | 0.612 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.307116e-01 | 0.481 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.575998e-01 | 0.447 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.182877e-01 | 0.661 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.962088e-01 | 0.528 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.305977e-01 | 0.637 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.064147e-01 | 0.514 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.064147e-01 | 0.514 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.636759e-01 | 0.579 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.633940e-01 | 0.579 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.469341e-01 | 0.607 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.267299e-01 | 0.644 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.182877e-01 | 0.661 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.962088e-01 | 0.528 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.962088e-01 | 0.528 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.135079e-01 | 0.504 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.225918e-01 | 0.652 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.808872e-01 | 0.551 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.424074e-01 | 0.354 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.477920e-01 | 0.459 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.456777e-01 | 0.610 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.386076e-01 | 0.622 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.353309e-01 | 0.628 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.582742e-01 | 0.446 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.817085e-01 | 0.550 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.822937e-01 | 0.739 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.329516e-01 | 0.364 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.575998e-01 | 0.447 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.082357e-01 | 0.389 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.207208e-01 | 0.376 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.923898e-01 | 0.716 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.542040e-01 | 0.812 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.706752e-01 | 0.768 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.534209e-01 | 0.596 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.817085e-01 | 0.550 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 3.148792e-01 | 0.502 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 2.267299e-01 | 0.644 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 2.267299e-01 | 0.644 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.767014e-01 | 0.424 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.941157e-01 | 0.712 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.329516e-01 | 0.364 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.320244e-01 | 0.479 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.845943e-01 | 0.734 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.845943e-01 | 0.734 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.135079e-01 | 0.504 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.674829e-01 | 0.776 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.966169e-01 | 0.706 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.329516e-01 | 0.364 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.099598e-01 | 0.509 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.232095e-01 | 0.651 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.448233e-01 | 0.462 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.135079e-01 | 0.504 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.305977e-01 | 0.637 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.521553e-01 | 0.598 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.427786e-01 | 0.615 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.818450e-01 | 0.740 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.722603e-01 | 0.764 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.469341e-01 | 0.607 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.817085e-01 | 0.550 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.817085e-01 | 0.550 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.588481e-01 | 0.799 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.148792e-01 | 0.502 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.465200e-01 | 0.460 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.267299e-01 | 0.644 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.822937e-01 | 0.739 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 4.054905e-01 | 0.392 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 4.054905e-01 | 0.392 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.054905e-01 | 0.392 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.329516e-01 | 0.364 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.647238e-01 | 0.438 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.814843e-01 | 0.419 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.397694e-01 | 0.620 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.082357e-01 | 0.389 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.305977e-01 | 0.637 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.430310e-01 | 0.614 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.192168e-01 | 0.496 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.397694e-01 | 0.620 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.742609e-01 | 0.759 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.742609e-01 | 0.759 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.962088e-01 | 0.528 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.808872e-01 | 0.551 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.375018e-01 | 0.472 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.940391e-01 | 0.712 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.387080e-01 | 0.358 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 1.706752e-01 | 0.768 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.192168e-01 | 0.496 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.629538e-01 | 0.440 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.397694e-01 | 0.620 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.331175e-01 | 0.477 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.817085e-01 | 0.550 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.614521e-01 | 0.583 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.492231e-01 | 0.603 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.484785e-01 | 0.828 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.555690e-01 | 0.592 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.307116e-01 | 0.481 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.467305e-01 | 0.460 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.932137e-01 | 0.533 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.706752e-01 | 0.768 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.706752e-01 | 0.768 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.923195e-01 | 0.406 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.469341e-01 | 0.607 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.767014e-01 | 0.424 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.940085e-01 | 0.404 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 4.122093e-01 | 0.385 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.386076e-01 | 0.622 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 3.064147e-01 | 0.514 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.440665e-01 | 0.612 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.264707e-01 | 0.486 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.305466e-01 | 0.366 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.320265e-01 | 0.364 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.106311e-01 | 0.387 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.754902e-01 | 0.756 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.941157e-01 | 0.712 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.793026e-01 | 0.746 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.940391e-01 | 0.712 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.133569e-01 | 0.671 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.817085e-01 | 0.550 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.148792e-01 | 0.502 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.767014e-01 | 0.424 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 4.054905e-01 | 0.392 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.329516e-01 | 0.364 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.329516e-01 | 0.364 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.808872e-01 | 0.551 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.300120e-01 | 0.638 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.370619e-01 | 0.472 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.813997e-01 | 0.551 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.633940e-01 | 0.579 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.034188e-01 | 0.518 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.022257e-01 | 0.396 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.030463e-01 | 0.692 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.030463e-01 | 0.692 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.111158e-01 | 0.386 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.440498e-01 | 0.463 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.093831e-01 | 0.510 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.320244e-01 | 0.479 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.490807e-01 | 0.827 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.148792e-01 | 0.502 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.267299e-01 | 0.644 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.408554e-01 | 0.618 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.023235e-01 | 0.395 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.705385e-01 | 0.768 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.645505e-01 | 0.577 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.320244e-01 | 0.479 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.065368e-01 | 0.514 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.981962e-01 | 0.525 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.057278e-01 | 0.515 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 2.104784e-01 | 0.677 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.465200e-01 | 0.460 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.647238e-01 | 0.438 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.755222e-01 | 0.560 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.575998e-01 | 0.447 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.789521e-01 | 0.554 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.440665e-01 | 0.612 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.830353e-01 | 0.417 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.481331e-01 | 0.829 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.267299e-01 | 0.644 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.651071e-01 | 0.438 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.207208e-01 | 0.376 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.354735e-01 | 0.361 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.469341e-01 | 0.607 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.817085e-01 | 0.550 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.817085e-01 | 0.550 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.148792e-01 | 0.502 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 3.148792e-01 | 0.502 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.767014e-01 | 0.424 | 0 | 0 |
| Biosynthesis of maresin conjugates in tissue regeneration (MCTR) | R-HSA-9026762 | 3.767014e-01 | 0.424 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.767014e-01 | 0.424 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.054905e-01 | 0.392 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.555690e-01 | 0.592 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.320244e-01 | 0.479 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.980533e-01 | 0.400 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.305466e-01 | 0.366 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 3.956704e-01 | 0.403 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.941157e-01 | 0.712 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.018463e-01 | 0.695 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.305466e-01 | 0.366 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.940391e-01 | 0.712 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.754902e-01 | 0.756 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 2.094878e-01 | 0.679 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 2.948583e-01 | 0.530 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.448233e-01 | 0.462 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.099598e-01 | 0.509 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 4.082357e-01 | 0.389 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 1.822937e-01 | 0.739 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.148792e-01 | 0.502 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.148792e-01 | 0.502 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.148792e-01 | 0.502 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.923898e-01 | 0.716 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.465200e-01 | 0.460 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.614521e-01 | 0.583 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.329516e-01 | 0.364 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.329516e-01 | 0.364 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.099598e-01 | 0.509 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.282933e-01 | 0.484 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.244476e-01 | 0.372 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.957246e-01 | 0.529 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.869500e-01 | 0.542 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.560575e-01 | 0.592 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.267299e-01 | 0.644 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.962088e-01 | 0.528 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.307116e-01 | 0.481 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.484785e-01 | 0.828 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.962088e-01 | 0.528 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.082834e-01 | 0.681 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.711388e-01 | 0.430 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 3.647238e-01 | 0.438 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.751969e-01 | 0.560 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.135079e-01 | 0.504 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.386076e-01 | 0.622 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.751969e-01 | 0.560 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.722688e-01 | 0.764 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 2.817085e-01 | 0.550 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.148792e-01 | 0.502 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.054905e-01 | 0.392 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.054905e-01 | 0.392 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.962088e-01 | 0.528 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.329516e-01 | 0.364 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.329516e-01 | 0.364 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.386076e-01 | 0.622 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.980533e-01 | 0.400 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.788455e-01 | 0.555 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 4.144127e-01 | 0.383 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.955265e-01 | 0.403 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 1.923898e-01 | 0.716 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 3.785466e-01 | 0.422 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 2.788455e-01 | 0.555 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.962088e-01 | 0.528 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.905334e-01 | 0.408 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 2.094878e-01 | 0.679 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 3.135079e-01 | 0.504 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 4.005985e-01 | 0.397 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.424074e-01 | 0.354 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.135079e-01 | 0.504 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.437163e-01 | 0.353 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.453167e-01 | 0.351 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.454128e-01 | 0.351 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.454128e-01 | 0.351 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.454128e-01 | 0.351 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 4.454128e-01 | 0.351 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.480803e-01 | 0.349 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.571035e-01 | 0.340 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.576022e-01 | 0.340 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.576022e-01 | 0.340 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.576022e-01 | 0.340 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.591459e-01 | 0.338 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.591459e-01 | 0.338 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.591459e-01 | 0.338 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.591459e-01 | 0.338 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.591459e-01 | 0.338 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 4.591459e-01 | 0.338 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.591459e-01 | 0.338 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 4.591459e-01 | 0.338 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.591459e-01 | 0.338 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.591459e-01 | 0.338 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.591459e-01 | 0.338 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.591459e-01 | 0.338 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.620835e-01 | 0.335 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 4.620835e-01 | 0.335 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.620835e-01 | 0.335 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.620835e-01 | 0.335 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 4.620835e-01 | 0.335 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.696764e-01 | 0.328 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.696764e-01 | 0.328 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.731832e-01 | 0.325 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.772345e-01 | 0.321 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.774635e-01 | 0.321 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.774635e-01 | 0.321 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.786121e-01 | 0.320 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.841316e-01 | 0.315 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.841316e-01 | 0.315 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 4.841316e-01 | 0.315 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.841316e-01 | 0.315 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.841316e-01 | 0.315 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.841316e-01 | 0.315 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.841316e-01 | 0.315 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.845025e-01 | 0.315 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.847340e-01 | 0.314 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.925534e-01 | 0.308 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.925719e-01 | 0.308 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.925719e-01 | 0.308 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 4.929853e-01 | 0.307 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.934509e-01 | 0.307 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.005625e-01 | 0.301 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.032999e-01 | 0.298 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.056372e-01 | 0.296 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.066944e-01 | 0.295 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.074011e-01 | 0.295 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.079645e-01 | 0.294 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.079645e-01 | 0.294 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.079645e-01 | 0.294 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.079645e-01 | 0.294 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.079645e-01 | 0.294 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.079645e-01 | 0.294 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.079645e-01 | 0.294 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 5.079645e-01 | 0.294 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.079645e-01 | 0.294 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.079645e-01 | 0.294 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.131705e-01 | 0.290 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.166842e-01 | 0.287 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.183881e-01 | 0.285 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.219444e-01 | 0.282 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.219444e-01 | 0.282 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.229502e-01 | 0.282 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.273132e-01 | 0.278 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.280839e-01 | 0.277 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.306978e-01 | 0.275 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.306978e-01 | 0.275 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.306978e-01 | 0.275 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.306978e-01 | 0.275 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.306978e-01 | 0.275 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.306978e-01 | 0.275 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.306978e-01 | 0.275 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.306978e-01 | 0.275 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.306978e-01 | 0.275 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.306978e-01 | 0.275 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.306978e-01 | 0.275 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.306978e-01 | 0.275 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.306978e-01 | 0.275 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 5.321294e-01 | 0.274 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.361968e-01 | 0.271 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.393036e-01 | 0.268 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.393326e-01 | 0.268 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.422215e-01 | 0.266 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.423247e-01 | 0.266 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.423547e-01 | 0.266 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.459021e-01 | 0.263 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.486165e-01 | 0.261 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.501541e-01 | 0.260 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.501541e-01 | 0.260 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.501541e-01 | 0.260 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.523820e-01 | 0.258 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.523820e-01 | 0.258 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.523820e-01 | 0.258 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.523820e-01 | 0.258 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.523820e-01 | 0.258 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 5.523820e-01 | 0.258 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 5.523820e-01 | 0.258 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.523820e-01 | 0.258 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.523820e-01 | 0.258 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.523820e-01 | 0.258 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 5.523820e-01 | 0.258 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.551817e-01 | 0.256 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.610862e-01 | 0.251 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.610862e-01 | 0.251 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.638131e-01 | 0.249 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.638131e-01 | 0.249 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.671956e-01 | 0.246 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.699986e-01 | 0.244 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.721309e-01 | 0.243 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.721309e-01 | 0.243 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.721476e-01 | 0.242 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.730655e-01 | 0.242 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.730655e-01 | 0.242 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.730655e-01 | 0.242 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.730655e-01 | 0.242 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.730655e-01 | 0.242 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.730655e-01 | 0.242 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.730655e-01 | 0.242 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 5.730655e-01 | 0.242 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.730655e-01 | 0.242 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.730655e-01 | 0.242 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 5.730655e-01 | 0.242 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.730655e-01 | 0.242 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.754119e-01 | 0.240 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.771715e-01 | 0.239 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.771715e-01 | 0.239 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 5.771715e-01 | 0.239 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.771715e-01 | 0.239 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.795207e-01 | 0.237 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.827364e-01 | 0.235 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.827364e-01 | 0.235 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.827364e-01 | 0.235 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 5.837224e-01 | 0.234 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.902280e-01 | 0.229 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.902280e-01 | 0.229 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.914448e-01 | 0.228 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.927945e-01 | 0.227 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.927945e-01 | 0.227 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.927945e-01 | 0.227 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.927945e-01 | 0.227 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.927945e-01 | 0.227 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.927945e-01 | 0.227 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 5.927945e-01 | 0.227 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.927945e-01 | 0.227 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.927945e-01 | 0.227 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.927945e-01 | 0.227 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.931734e-01 | 0.227 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.029820e-01 | 0.220 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 6.084186e-01 | 0.216 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.116130e-01 | 0.214 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.116130e-01 | 0.214 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.116130e-01 | 0.214 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.116130e-01 | 0.214 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.116130e-01 | 0.214 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.116130e-01 | 0.214 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.116130e-01 | 0.214 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.116130e-01 | 0.214 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.135334e-01 | 0.212 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 6.135334e-01 | 0.212 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.141243e-01 | 0.212 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.150208e-01 | 0.211 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.150365e-01 | 0.211 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.154335e-01 | 0.211 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 6.154335e-01 | 0.211 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.154335e-01 | 0.211 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.154903e-01 | 0.211 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.178109e-01 | 0.209 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.189875e-01 | 0.208 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 6.270420e-01 | 0.203 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.275833e-01 | 0.202 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.295628e-01 | 0.201 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.295628e-01 | 0.201 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.295628e-01 | 0.201 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.295628e-01 | 0.201 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 6.295628e-01 | 0.201 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.295628e-01 | 0.201 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.295628e-01 | 0.201 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.330327e-01 | 0.199 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.331967e-01 | 0.198 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 6.331967e-01 | 0.198 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.331967e-01 | 0.198 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 6.350451e-01 | 0.197 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.394326e-01 | 0.194 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.394326e-01 | 0.194 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.427639e-01 | 0.192 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.427639e-01 | 0.192 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.427639e-01 | 0.192 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 6.427639e-01 | 0.192 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.466842e-01 | 0.189 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.466842e-01 | 0.189 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.466842e-01 | 0.189 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.466842e-01 | 0.189 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.466842e-01 | 0.189 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.509832e-01 | 0.186 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.538644e-01 | 0.185 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.566817e-01 | 0.183 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 6.569194e-01 | 0.182 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.613661e-01 | 0.180 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 6.622375e-01 | 0.179 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.622375e-01 | 0.179 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.622375e-01 | 0.179 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.630151e-01 | 0.178 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.630151e-01 | 0.178 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.630151e-01 | 0.178 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.630151e-01 | 0.178 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.630151e-01 | 0.178 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.630151e-01 | 0.178 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.630151e-01 | 0.178 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.630151e-01 | 0.178 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 6.630151e-01 | 0.178 | 0 | 0 |
| Biosynthesis of DHA-derived sulfido conjugates | R-HSA-9026395 | 6.630151e-01 | 0.178 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 6.630151e-01 | 0.178 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.630151e-01 | 0.178 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.694258e-01 | 0.174 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.695915e-01 | 0.174 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.731981e-01 | 0.172 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.785922e-01 | 0.168 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.785922e-01 | 0.168 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.785922e-01 | 0.168 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.785922e-01 | 0.168 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.785922e-01 | 0.168 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 6.838681e-01 | 0.165 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 6.838681e-01 | 0.165 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.838681e-01 | 0.165 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.879356e-01 | 0.162 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 6.879356e-01 | 0.162 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.934502e-01 | 0.159 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.934502e-01 | 0.159 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.934502e-01 | 0.159 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.934502e-01 | 0.159 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.934502e-01 | 0.159 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 6.934502e-01 | 0.159 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.934502e-01 | 0.159 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.942511e-01 | 0.158 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.952003e-01 | 0.158 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.964372e-01 | 0.157 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 6.967780e-01 | 0.157 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 6.967780e-01 | 0.157 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.025215e-01 | 0.153 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 7.043506e-01 | 0.152 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.068185e-01 | 0.151 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 7.076221e-01 | 0.150 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.076221e-01 | 0.150 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.076221e-01 | 0.150 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.076221e-01 | 0.150 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 7.076221e-01 | 0.150 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.076221e-01 | 0.150 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.076221e-01 | 0.150 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 7.076221e-01 | 0.150 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.097149e-01 | 0.149 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.097149e-01 | 0.149 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.114504e-01 | 0.148 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 7.129118e-01 | 0.147 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.129118e-01 | 0.147 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.141707e-01 | 0.146 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 7.141707e-01 | 0.146 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.141707e-01 | 0.146 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.141707e-01 | 0.146 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.141707e-01 | 0.146 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.208867e-01 | 0.142 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.208867e-01 | 0.142 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 7.208867e-01 | 0.142 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.211397e-01 | 0.142 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.211397e-01 | 0.142 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.211397e-01 | 0.142 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.211397e-01 | 0.142 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.211397e-01 | 0.142 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.237157e-01 | 0.140 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.237157e-01 | 0.140 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.237157e-01 | 0.140 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.237157e-01 | 0.140 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.287211e-01 | 0.137 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.287211e-01 | 0.137 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.290288e-01 | 0.137 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 7.334523e-01 | 0.135 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.340331e-01 | 0.134 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.340331e-01 | 0.134 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.340331e-01 | 0.134 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.340331e-01 | 0.134 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.340331e-01 | 0.134 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.340331e-01 | 0.134 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.340331e-01 | 0.134 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.340331e-01 | 0.134 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.340331e-01 | 0.134 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.340331e-01 | 0.134 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 7.340331e-01 | 0.134 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.340331e-01 | 0.134 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.340331e-01 | 0.134 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.340331e-01 | 0.134 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.346400e-01 | 0.134 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.363175e-01 | 0.133 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.372033e-01 | 0.132 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 7.419981e-01 | 0.130 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.419981e-01 | 0.130 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.437763e-01 | 0.129 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.463311e-01 | 0.127 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.463311e-01 | 0.127 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.463311e-01 | 0.127 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.463311e-01 | 0.127 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.463311e-01 | 0.127 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.463311e-01 | 0.127 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 7.502085e-01 | 0.125 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 7.507450e-01 | 0.125 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.507450e-01 | 0.125 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.510660e-01 | 0.124 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.510660e-01 | 0.124 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.565177e-01 | 0.121 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.580612e-01 | 0.120 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.580612e-01 | 0.120 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.580612e-01 | 0.120 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.580612e-01 | 0.120 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.581884e-01 | 0.120 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.592354e-01 | 0.120 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 7.612692e-01 | 0.118 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.627032e-01 | 0.118 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 7.651454e-01 | 0.116 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.665720e-01 | 0.115 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.687658e-01 | 0.114 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.692496e-01 | 0.114 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.692496e-01 | 0.114 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.692496e-01 | 0.114 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.692496e-01 | 0.114 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.692496e-01 | 0.114 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.692496e-01 | 0.114 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.692496e-01 | 0.114 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.692496e-01 | 0.114 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 7.719387e-01 | 0.112 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.719387e-01 | 0.112 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.719387e-01 | 0.112 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.754669e-01 | 0.110 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.754669e-01 | 0.110 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.754669e-01 | 0.110 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.754669e-01 | 0.110 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.754669e-01 | 0.110 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.755587e-01 | 0.110 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.799211e-01 | 0.108 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.799211e-01 | 0.108 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.799211e-01 | 0.108 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.799211e-01 | 0.108 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.799211e-01 | 0.108 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.799211e-01 | 0.108 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.832183e-01 | 0.106 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.832183e-01 | 0.106 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.850429e-01 | 0.105 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.885487e-01 | 0.103 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.900998e-01 | 0.102 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.900998e-01 | 0.102 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.900998e-01 | 0.102 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.900998e-01 | 0.102 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.900998e-01 | 0.102 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.900998e-01 | 0.102 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 7.900998e-01 | 0.102 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 7.900998e-01 | 0.102 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.900998e-01 | 0.102 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.907338e-01 | 0.102 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.913580e-01 | 0.102 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.944684e-01 | 0.100 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.952595e-01 | 0.099 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.955656e-01 | 0.099 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.957132e-01 | 0.099 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.967275e-01 | 0.099 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.972723e-01 | 0.098 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.980184e-01 | 0.098 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.980184e-01 | 0.098 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 7.980184e-01 | 0.098 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.998083e-01 | 0.097 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.998083e-01 | 0.097 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.998083e-01 | 0.097 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.998083e-01 | 0.097 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.998083e-01 | 0.097 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.998083e-01 | 0.097 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.998083e-01 | 0.097 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 8.001762e-01 | 0.097 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.026203e-01 | 0.095 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.035253e-01 | 0.095 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.050776e-01 | 0.094 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.090683e-01 | 0.092 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.090683e-01 | 0.092 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.093821e-01 | 0.092 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.093821e-01 | 0.092 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 8.114824e-01 | 0.091 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 8.119165e-01 | 0.090 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.175457e-01 | 0.087 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.179006e-01 | 0.087 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.179006e-01 | 0.087 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.179006e-01 | 0.087 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.179006e-01 | 0.087 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.185404e-01 | 0.087 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.185404e-01 | 0.087 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.206540e-01 | 0.086 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.217104e-01 | 0.085 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.249546e-01 | 0.084 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.249546e-01 | 0.084 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.263247e-01 | 0.083 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.263247e-01 | 0.083 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.263247e-01 | 0.083 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.263247e-01 | 0.083 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.277434e-01 | 0.082 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 8.311643e-01 | 0.080 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.311643e-01 | 0.080 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.311643e-01 | 0.080 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 8.311643e-01 | 0.080 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.313533e-01 | 0.080 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.337536e-01 | 0.079 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.343597e-01 | 0.079 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.343597e-01 | 0.079 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 8.364944e-01 | 0.078 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.371747e-01 | 0.077 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.420234e-01 | 0.075 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.420234e-01 | 0.075 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.420234e-01 | 0.075 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.420234e-01 | 0.075 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 8.420234e-01 | 0.075 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.451355e-01 | 0.073 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.482878e-01 | 0.071 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.493329e-01 | 0.071 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.493329e-01 | 0.071 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.500146e-01 | 0.071 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.511141e-01 | 0.070 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.557280e-01 | 0.068 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.563047e-01 | 0.067 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.563047e-01 | 0.067 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.563047e-01 | 0.067 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.563047e-01 | 0.067 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.602164e-01 | 0.065 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.602164e-01 | 0.065 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.602164e-01 | 0.065 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.629543e-01 | 0.064 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 8.645819e-01 | 0.063 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.692965e-01 | 0.061 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.692965e-01 | 0.061 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.692965e-01 | 0.061 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.692965e-01 | 0.061 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.692965e-01 | 0.061 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.692965e-01 | 0.061 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.692965e-01 | 0.061 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.698626e-01 | 0.061 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.729543e-01 | 0.059 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 8.753456e-01 | 0.058 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.753456e-01 | 0.058 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.753456e-01 | 0.058 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.769663e-01 | 0.057 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.769663e-01 | 0.057 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.783322e-01 | 0.056 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.789493e-01 | 0.056 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 8.808656e-01 | 0.055 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.808656e-01 | 0.055 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 8.811151e-01 | 0.055 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 8.811151e-01 | 0.055 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.811151e-01 | 0.055 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.844757e-01 | 0.053 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.846545e-01 | 0.053 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.866179e-01 | 0.052 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.866179e-01 | 0.052 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.866179e-01 | 0.052 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.866179e-01 | 0.052 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.866179e-01 | 0.052 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.874085e-01 | 0.052 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 8.874172e-01 | 0.052 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.874172e-01 | 0.052 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.875642e-01 | 0.052 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.883356e-01 | 0.051 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.901368e-01 | 0.051 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.901368e-01 | 0.051 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.915607e-01 | 0.050 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.915607e-01 | 0.050 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.915607e-01 | 0.050 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.918663e-01 | 0.050 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.918663e-01 | 0.050 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.918663e-01 | 0.050 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.918663e-01 | 0.050 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.918663e-01 | 0.050 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.918663e-01 | 0.050 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.918663e-01 | 0.050 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.918663e-01 | 0.050 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.918663e-01 | 0.050 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.953841e-01 | 0.048 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.955622e-01 | 0.048 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.968720e-01 | 0.047 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 8.968720e-01 | 0.047 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.968720e-01 | 0.047 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.968720e-01 | 0.047 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.969149e-01 | 0.047 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.969149e-01 | 0.047 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.969149e-01 | 0.047 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.987564e-01 | 0.046 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.004638e-01 | 0.046 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.016464e-01 | 0.045 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.016464e-01 | 0.045 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.016464e-01 | 0.045 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.016464e-01 | 0.045 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.016464e-01 | 0.045 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.016464e-01 | 0.045 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.016464e-01 | 0.045 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.020304e-01 | 0.045 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.052087e-01 | 0.043 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.061144e-01 | 0.043 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.061999e-01 | 0.043 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.061999e-01 | 0.043 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 9.061999e-01 | 0.043 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.061999e-01 | 0.043 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.081957e-01 | 0.042 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.082934e-01 | 0.042 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.105430e-01 | 0.041 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.105430e-01 | 0.041 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.105430e-01 | 0.041 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.135859e-01 | 0.039 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.135859e-01 | 0.039 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 9.146851e-01 | 0.039 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.186358e-01 | 0.037 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.186358e-01 | 0.037 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.186358e-01 | 0.037 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.186358e-01 | 0.037 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.197425e-01 | 0.036 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.197425e-01 | 0.036 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.223933e-01 | 0.035 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.223933e-01 | 0.035 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.224037e-01 | 0.035 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.224037e-01 | 0.035 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.224037e-01 | 0.035 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.259973e-01 | 0.033 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.259973e-01 | 0.033 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.259973e-01 | 0.033 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.294248e-01 | 0.032 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 9.304051e-01 | 0.031 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.326936e-01 | 0.030 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.326936e-01 | 0.030 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.345810e-01 | 0.029 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.345810e-01 | 0.029 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.358113e-01 | 0.029 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.365827e-01 | 0.028 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 9.366836e-01 | 0.028 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.387847e-01 | 0.027 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.387847e-01 | 0.027 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.387847e-01 | 0.027 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.388940e-01 | 0.027 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.403417e-01 | 0.027 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.412259e-01 | 0.026 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 9.416206e-01 | 0.026 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.416206e-01 | 0.026 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.428795e-01 | 0.026 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.437060e-01 | 0.025 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.440172e-01 | 0.025 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.443253e-01 | 0.025 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.443253e-01 | 0.025 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.443253e-01 | 0.025 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.443253e-01 | 0.025 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.443253e-01 | 0.025 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.443253e-01 | 0.025 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.448167e-01 | 0.025 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.448167e-01 | 0.025 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.469048e-01 | 0.024 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.477245e-01 | 0.023 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.477245e-01 | 0.023 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.504784e-01 | 0.022 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 9.517112e-01 | 0.021 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.522434e-01 | 0.021 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.539489e-01 | 0.020 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.557194e-01 | 0.020 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 9.560831e-01 | 0.020 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.560831e-01 | 0.020 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.560831e-01 | 0.020 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.581184e-01 | 0.019 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.593241e-01 | 0.018 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.600596e-01 | 0.018 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.600596e-01 | 0.018 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.600596e-01 | 0.018 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.600596e-01 | 0.018 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.600596e-01 | 0.018 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.600596e-01 | 0.018 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.600596e-01 | 0.018 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.603279e-01 | 0.018 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.619109e-01 | 0.017 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.619109e-01 | 0.017 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.619109e-01 | 0.017 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.619109e-01 | 0.017 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.621497e-01 | 0.017 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.630932e-01 | 0.016 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.636765e-01 | 0.016 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.643122e-01 | 0.016 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.654230e-01 | 0.015 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.665360e-01 | 0.015 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.665565e-01 | 0.015 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.669662e-01 | 0.015 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.669662e-01 | 0.015 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.684978e-01 | 0.014 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.685678e-01 | 0.014 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.685732e-01 | 0.014 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.704278e-01 | 0.013 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.711949e-01 | 0.013 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.713514e-01 | 0.013 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.724718e-01 | 0.012 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.725428e-01 | 0.012 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.726799e-01 | 0.012 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.733951e-01 | 0.012 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.733951e-01 | 0.012 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.738307e-01 | 0.012 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.751551e-01 | 0.011 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.751551e-01 | 0.011 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.752722e-01 | 0.011 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.763074e-01 | 0.010 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.763074e-01 | 0.010 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.774063e-01 | 0.010 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.791237e-01 | 0.009 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.794538e-01 | 0.009 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.794538e-01 | 0.009 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.804070e-01 | 0.009 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.821828e-01 | 0.008 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.830095e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.830095e-01 | 0.007 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.844505e-01 | 0.007 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.852668e-01 | 0.006 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.852668e-01 | 0.006 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.855391e-01 | 0.006 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.855391e-01 | 0.006 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.872245e-01 | 0.006 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.874158e-01 | 0.005 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.878176e-01 | 0.005 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 9.887027e-01 | 0.005 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.899272e-01 | 0.004 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.908409e-01 | 0.004 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.928294e-01 | 0.003 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.928437e-01 | 0.003 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.931147e-01 | 0.003 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.934448e-01 | 0.003 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.934980e-01 | 0.003 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.937396e-01 | 0.003 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.938082e-01 | 0.003 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.943078e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.945723e-01 | 0.002 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.946937e-01 | 0.002 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.955131e-01 | 0.002 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.960238e-01 | 0.002 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.965672e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.967847e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.969342e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.970768e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.974863e-01 | 0.001 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.975819e-01 | 0.001 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.976166e-01 | 0.001 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.976963e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.978966e-01 | 0.001 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.982045e-01 | 0.001 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.983496e-01 | 0.001 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.983496e-01 | 0.001 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.984997e-01 | 0.001 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.986361e-01 | 0.001 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.989254e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.990686e-01 | 0.000 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.991120e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.993127e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.993641e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.995225e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.995659e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.996055e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.998483e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999032e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999084e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999133e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999145e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999328e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999331e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999706e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999716e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999775e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999876e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999897e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999933e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999945e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999994e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999997e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 8.881784e-16 | 15.051 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.771561e-16 | 15.109 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.884981e-15 | 14.311 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.632028e-14 | 13.787 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.632028e-14 | 13.787 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.597123e-14 | 13.444 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.130030e-14 | 13.384 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.491030e-13 | 12.827 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.345102e-13 | 12.476 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.101786e-13 | 12.215 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.503509e-13 | 12.022 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.093015e-12 | 11.961 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.032463e-12 | 11.518 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.530287e-12 | 11.452 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.030554e-12 | 11.395 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.030554e-12 | 11.395 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.136003e-12 | 11.289 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.661138e-12 | 11.247 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.515211e-12 | 11.124 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.525314e-12 | 11.123 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.294787e-12 | 11.032 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 8.940071e-12 | 11.049 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.031553e-12 | 11.044 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.226741e-11 | 10.911 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.788914e-11 | 10.555 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.607270e-11 | 10.443 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.207945e-11 | 10.376 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.540956e-11 | 10.343 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.171819e-11 | 10.286 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.105883e-11 | 10.091 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.105883e-11 | 10.091 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.465506e-11 | 10.024 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.052809e-10 | 9.978 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.081116e-10 | 9.966 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.270838e-10 | 9.896 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.828665e-10 | 9.738 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.881937e-10 | 9.725 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.115567e-10 | 9.675 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.316501e-10 | 9.635 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.604824e-10 | 9.584 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.587252e-10 | 9.587 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.563073e-10 | 9.591 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.748124e-10 | 9.561 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.742321e-10 | 9.562 | 1 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.538495e-10 | 9.343 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.561245e-10 | 9.341 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.858853e-10 | 9.232 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.046263e-10 | 9.219 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.297221e-10 | 9.201 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 6.383738e-10 | 9.195 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 7.738004e-10 | 9.111 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.904772e-10 | 9.050 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.016855e-10 | 9.045 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.016536e-09 | 8.993 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.047994e-09 | 8.980 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.234319e-09 | 8.909 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.278907e-09 | 8.893 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.353677e-09 | 8.868 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.559015e-09 | 8.807 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.687933e-09 | 8.773 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.687933e-09 | 8.773 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.761877e-09 | 8.754 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.757738e-09 | 8.755 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.102772e-09 | 8.677 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.297396e-09 | 8.639 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.519255e-09 | 8.599 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.224261e-09 | 8.492 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.632518e-09 | 8.440 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.817244e-09 | 8.418 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 4.689741e-09 | 8.329 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.548503e-09 | 8.256 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.814452e-09 | 8.235 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.250858e-09 | 8.204 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.394565e-09 | 8.194 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 7.526694e-09 | 8.123 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 9.361056e-09 | 8.029 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 9.423222e-09 | 8.026 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.839507e-09 | 8.007 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.191538e-08 | 7.924 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.263434e-08 | 7.898 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.548125e-08 | 7.810 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.621077e-08 | 7.790 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.649118e-08 | 7.783 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.985655e-08 | 7.702 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.965639e-08 | 7.706 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.011907e-08 | 7.696 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.047166e-08 | 7.689 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.382614e-08 | 7.623 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.694682e-08 | 7.569 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.694682e-08 | 7.569 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.729446e-08 | 7.564 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.729446e-08 | 7.564 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.157041e-08 | 7.501 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.315074e-08 | 7.480 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.352285e-08 | 7.475 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.644733e-08 | 7.438 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.443236e-08 | 7.352 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.359978e-08 | 7.271 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.482534e-08 | 7.188 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.559276e-08 | 7.183 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.601049e-08 | 7.018 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 9.601049e-08 | 7.018 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.111294e-07 | 6.954 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.382653e-07 | 6.859 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.427022e-07 | 6.846 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.729118e-07 | 6.762 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.910921e-07 | 6.719 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.470288e-07 | 6.607 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.833472e-07 | 6.548 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.593018e-07 | 6.445 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 4.653886e-07 | 6.332 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.360977e-07 | 6.271 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.855522e-07 | 6.232 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.468121e-07 | 6.189 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.488688e-07 | 6.188 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.194503e-07 | 6.208 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 6.687442e-07 | 6.175 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.527843e-07 | 6.123 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.356463e-07 | 6.078 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.759925e-07 | 6.057 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.465007e-07 | 6.024 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.060910e-06 | 5.974 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.122131e-06 | 5.950 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.285695e-06 | 5.891 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.262278e-06 | 5.899 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.248829e-06 | 5.903 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.231844e-06 | 5.909 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.321326e-06 | 5.879 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.345774e-06 | 5.871 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.534825e-06 | 5.814 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.999770e-06 | 5.699 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.186787e-06 | 5.660 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.417612e-06 | 5.617 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.417612e-06 | 5.617 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.419706e-06 | 5.616 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.591791e-06 | 5.586 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.592719e-06 | 5.586 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.877863e-06 | 5.541 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.822276e-06 | 5.549 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.179893e-06 | 5.498 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.475941e-06 | 5.459 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.691737e-06 | 5.433 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.041455e-06 | 5.393 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.056278e-06 | 5.392 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.056278e-06 | 5.392 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.636719e-06 | 5.334 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.647116e-06 | 5.333 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.832391e-06 | 5.316 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.705748e-06 | 5.244 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.705748e-06 | 5.244 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.236494e-06 | 5.281 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.347119e-06 | 5.272 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.441437e-06 | 5.191 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 6.907311e-06 | 5.161 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.342081e-06 | 5.134 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.380882e-06 | 5.132 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.437674e-06 | 5.129 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.926453e-06 | 5.101 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.348053e-06 | 5.078 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.083269e-06 | 5.042 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.009099e-05 | 4.996 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.120386e-05 | 4.951 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.120386e-05 | 4.951 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.120386e-05 | 4.951 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.120386e-05 | 4.951 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.082788e-05 | 4.965 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.156659e-05 | 4.937 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.185101e-05 | 4.926 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.111550e-05 | 4.954 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.063477e-05 | 4.973 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.257362e-05 | 4.901 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.258651e-05 | 4.900 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.314892e-05 | 4.881 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.334648e-05 | 4.875 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.357141e-05 | 4.867 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.373381e-05 | 4.862 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.583076e-05 | 4.800 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.594356e-05 | 4.797 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.594356e-05 | 4.797 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.772955e-05 | 4.751 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.895802e-05 | 4.722 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.961423e-05 | 4.707 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.979543e-05 | 4.703 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.039996e-05 | 4.690 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.164537e-05 | 4.665 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.164537e-05 | 4.665 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.351751e-05 | 4.629 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.324811e-05 | 4.478 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.199671e-05 | 4.495 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.610172e-05 | 4.442 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.726266e-05 | 4.429 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.098903e-05 | 4.387 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.348381e-05 | 4.362 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.395148e-05 | 4.357 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.395148e-05 | 4.357 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.615146e-05 | 4.336 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.782371e-05 | 4.320 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.831277e-05 | 4.316 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.074854e-05 | 4.295 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.200386e-05 | 4.284 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.471115e-05 | 4.262 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.519601e-05 | 4.258 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.519601e-05 | 4.258 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.521893e-05 | 4.186 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.652882e-05 | 4.177 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 6.653974e-05 | 4.177 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 6.653974e-05 | 4.177 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.664991e-05 | 4.176 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.664991e-05 | 4.176 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.777389e-05 | 4.109 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.495754e-05 | 4.071 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 8.608625e-05 | 4.065 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.533618e-05 | 4.069 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.195706e-05 | 4.086 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.933396e-05 | 4.049 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.032677e-05 | 4.044 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 9.223726e-05 | 4.035 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.247726e-05 | 4.034 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.256334e-05 | 4.034 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 9.467239e-05 | 4.024 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.467239e-05 | 4.024 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 9.467239e-05 | 4.024 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 9.467239e-05 | 4.024 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.544887e-05 | 4.020 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 9.576559e-05 | 4.019 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.072766e-04 | 3.969 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.072766e-04 | 3.969 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.100271e-04 | 3.959 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.100271e-04 | 3.959 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.100271e-04 | 3.959 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.152248e-04 | 3.938 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.230177e-04 | 3.910 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.331853e-04 | 3.876 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.355065e-04 | 3.868 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.412212e-04 | 3.850 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.583818e-04 | 3.800 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.781066e-04 | 3.749 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.839406e-04 | 3.735 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.858710e-04 | 3.731 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.300885e-04 | 3.638 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.186264e-04 | 3.660 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.269007e-04 | 3.644 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.269007e-04 | 3.644 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.261244e-04 | 3.646 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.300885e-04 | 3.638 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.126343e-04 | 3.672 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.003282e-04 | 3.698 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.965360e-04 | 3.707 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.161008e-04 | 3.665 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.194646e-04 | 3.659 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.194646e-04 | 3.659 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.334830e-04 | 3.632 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.405128e-04 | 3.619 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.445290e-04 | 3.612 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.577424e-04 | 3.589 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 2.711019e-04 | 3.567 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 2.711019e-04 | 3.567 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.986954e-04 | 3.525 | 0 | 0 |
| Translation | R-HSA-72766 | 2.994169e-04 | 3.524 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.999582e-04 | 3.523 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.003667e-04 | 3.522 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.316660e-04 | 3.479 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.334635e-04 | 3.477 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.492792e-04 | 3.457 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.492792e-04 | 3.457 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.516002e-04 | 3.454 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.667924e-04 | 3.436 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.667924e-04 | 3.436 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.706532e-04 | 3.431 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.706532e-04 | 3.431 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.706532e-04 | 3.431 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.706532e-04 | 3.431 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.742311e-04 | 3.427 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.973996e-04 | 3.401 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.978247e-04 | 3.400 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.120930e-04 | 3.385 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.120930e-04 | 3.385 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.257758e-04 | 3.371 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.735031e-04 | 3.325 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.735031e-04 | 3.325 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.905205e-04 | 3.309 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.021757e-04 | 3.299 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.101982e-04 | 3.292 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 5.250249e-04 | 3.280 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.263420e-04 | 3.279 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.640151e-04 | 3.178 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.640151e-04 | 3.178 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.184044e-04 | 3.209 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.480284e-04 | 3.261 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 6.640151e-04 | 3.178 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 5.480284e-04 | 3.261 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.184044e-04 | 3.209 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.646280e-04 | 3.248 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.925603e-04 | 3.227 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.781371e-04 | 3.169 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.444134e-04 | 3.128 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.444134e-04 | 3.128 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.472973e-04 | 3.127 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 7.472973e-04 | 3.127 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 7.561434e-04 | 3.121 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.670162e-04 | 3.115 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.825871e-04 | 3.106 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.825871e-04 | 3.106 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.324536e-04 | 3.080 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 8.635618e-04 | 3.064 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.235201e-04 | 3.035 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.416357e-04 | 3.026 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.451082e-04 | 3.025 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.644150e-04 | 3.016 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.828291e-04 | 3.008 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.017479e-03 | 2.992 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.017479e-03 | 2.992 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.041151e-03 | 2.982 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.054831e-03 | 2.977 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.058244e-03 | 2.975 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.058244e-03 | 2.975 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.084931e-03 | 2.965 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.084931e-03 | 2.965 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.106389e-03 | 2.956 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.221521e-03 | 2.913 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.221521e-03 | 2.913 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.236019e-03 | 2.908 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.272033e-03 | 2.896 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.280453e-03 | 2.893 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.303947e-03 | 2.885 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.341568e-03 | 2.872 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.348046e-03 | 2.870 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.408842e-03 | 2.851 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.408842e-03 | 2.851 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.408842e-03 | 2.851 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.466193e-03 | 2.834 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.466193e-03 | 2.834 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.468735e-03 | 2.833 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.469780e-03 | 2.833 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.469780e-03 | 2.833 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.538533e-03 | 2.813 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.591260e-03 | 2.798 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.603860e-03 | 2.795 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.615027e-03 | 2.792 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.618603e-03 | 2.791 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.618603e-03 | 2.791 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.618603e-03 | 2.791 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.718385e-03 | 2.765 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.718385e-03 | 2.765 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.745751e-03 | 2.758 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.777671e-03 | 2.750 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.937917e-03 | 2.713 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.937917e-03 | 2.713 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.981513e-03 | 2.703 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.981513e-03 | 2.703 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.999088e-03 | 2.699 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.999088e-03 | 2.699 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.999088e-03 | 2.699 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.999088e-03 | 2.699 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.999088e-03 | 2.699 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.282923e-03 | 2.642 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.281900e-03 | 2.642 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.552717e-03 | 2.593 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.401818e-03 | 2.619 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.154901e-03 | 2.667 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.632492e-03 | 2.580 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.314684e-03 | 2.636 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.314684e-03 | 2.636 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.401818e-03 | 2.619 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.375913e-03 | 2.624 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 2.113083e-03 | 2.675 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.668071e-03 | 2.574 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.004816e-03 | 2.698 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.113083e-03 | 2.675 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.668071e-03 | 2.574 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.282923e-03 | 2.642 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.314684e-03 | 2.636 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.089197e-03 | 2.680 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.632492e-03 | 2.580 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.721021e-03 | 2.565 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.721021e-03 | 2.565 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.721021e-03 | 2.565 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.721021e-03 | 2.565 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.797773e-03 | 2.553 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.062241e-03 | 2.514 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.062241e-03 | 2.514 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.062241e-03 | 2.514 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.062241e-03 | 2.514 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.185347e-03 | 2.497 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.200231e-03 | 2.495 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.204633e-03 | 2.494 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.204633e-03 | 2.494 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 3.204633e-03 | 2.494 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.274782e-03 | 2.485 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.459657e-03 | 2.461 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.540056e-03 | 2.451 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.695378e-03 | 2.432 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.811436e-03 | 2.419 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.811436e-03 | 2.419 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.820426e-03 | 2.418 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.985346e-03 | 2.400 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.014863e-03 | 2.396 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 4.014863e-03 | 2.396 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 4.014863e-03 | 2.396 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.014863e-03 | 2.396 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.300676e-03 | 2.366 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.420840e-03 | 2.354 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.455039e-03 | 2.351 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.544780e-03 | 2.342 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.632145e-03 | 2.334 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 4.967809e-03 | 2.304 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.989332e-03 | 2.302 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.109572e-03 | 2.292 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.109572e-03 | 2.292 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.259062e-03 | 2.279 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.281871e-03 | 2.277 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 5.403156e-03 | 2.267 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 5.403156e-03 | 2.267 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 5.404468e-03 | 2.267 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.724029e-03 | 2.242 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 5.748062e-03 | 2.240 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.748062e-03 | 2.240 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 5.755379e-03 | 2.240 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.825520e-03 | 2.235 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.825520e-03 | 2.235 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.873123e-03 | 2.231 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.960511e-03 | 2.225 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.960511e-03 | 2.225 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.000392e-03 | 2.222 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.070888e-03 | 2.217 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.289746e-03 | 2.201 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.289746e-03 | 2.201 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.338322e-03 | 2.198 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.423936e-03 | 2.192 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.461494e-03 | 2.190 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.612947e-03 | 2.180 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.647228e-03 | 2.177 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.647228e-03 | 2.177 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 6.647302e-03 | 2.177 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 6.729401e-03 | 2.172 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 7.231342e-03 | 2.141 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.304610e-03 | 2.136 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 7.335654e-03 | 2.135 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 7.335654e-03 | 2.135 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 7.335654e-03 | 2.135 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.552233e-03 | 2.122 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 7.552233e-03 | 2.122 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.573451e-03 | 2.121 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.835594e-03 | 2.106 | 0 | 0 |
| Disease | R-HSA-1643685 | 7.881359e-03 | 2.103 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.010621e-03 | 2.096 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.029519e-03 | 2.095 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 8.068375e-03 | 2.093 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.068375e-03 | 2.093 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 8.097992e-03 | 2.092 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.100076e-03 | 2.092 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.100076e-03 | 2.092 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.458834e-03 | 2.073 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.476975e-03 | 2.072 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 8.773311e-03 | 2.057 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 8.773311e-03 | 2.057 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.911332e-03 | 2.050 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.911332e-03 | 2.050 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.911332e-03 | 2.050 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.911332e-03 | 2.050 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.976053e-03 | 2.047 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 9.285956e-03 | 2.032 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 9.318090e-03 | 2.031 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 9.371306e-03 | 2.028 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.173651e-02 | 1.930 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 9.682662e-03 | 2.014 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.325450e-02 | 1.878 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.163628e-02 | 1.934 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.039462e-02 | 1.983 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.039462e-02 | 1.983 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.039462e-02 | 1.983 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.422870e-02 | 1.847 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.753902e-03 | 2.011 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.957840e-03 | 2.002 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.957840e-03 | 2.002 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.395953e-02 | 1.855 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.253695e-02 | 1.902 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.163628e-02 | 1.934 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.422548e-02 | 1.847 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.183557e-02 | 1.927 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.173651e-02 | 1.930 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.101719e-02 | 1.958 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.163628e-02 | 1.934 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.220986e-02 | 1.913 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.013530e-02 | 1.994 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.176482e-02 | 1.929 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.422548e-02 | 1.847 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.081352e-02 | 1.966 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.036013e-02 | 1.985 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.209847e-02 | 1.917 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.158238e-02 | 1.936 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.422870e-02 | 1.847 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.193213e-02 | 1.923 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.392161e-02 | 1.856 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.113283e-02 | 1.953 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.193213e-02 | 1.923 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.163628e-02 | 1.934 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.156263e-02 | 1.937 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.338228e-02 | 1.873 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.338228e-02 | 1.873 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.163628e-02 | 1.934 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.499267e-02 | 1.824 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.502576e-02 | 1.823 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.513289e-02 | 1.820 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.609836e-02 | 1.793 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.623421e-02 | 1.790 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.623421e-02 | 1.790 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.623421e-02 | 1.790 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.623921e-02 | 1.789 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.623921e-02 | 1.789 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.641999e-02 | 1.785 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.641999e-02 | 1.785 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.641999e-02 | 1.785 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.646021e-02 | 1.784 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.646021e-02 | 1.784 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.646021e-02 | 1.784 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.646021e-02 | 1.784 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.661078e-02 | 1.780 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.696868e-02 | 1.770 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.715285e-02 | 1.766 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.715285e-02 | 1.766 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.731990e-02 | 1.761 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.748224e-02 | 1.757 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.759625e-02 | 1.755 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.791399e-02 | 1.747 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.823616e-02 | 1.739 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.891278e-02 | 1.723 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.915036e-02 | 1.718 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.919163e-02 | 1.717 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.014146e-02 | 1.696 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.014146e-02 | 1.696 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.014146e-02 | 1.696 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.014146e-02 | 1.696 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.014146e-02 | 1.696 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.014146e-02 | 1.696 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.014146e-02 | 1.696 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.014146e-02 | 1.696 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.014146e-02 | 1.696 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.014146e-02 | 1.696 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.014146e-02 | 1.696 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.014146e-02 | 1.696 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.014591e-02 | 1.696 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.021017e-02 | 1.694 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.043026e-02 | 1.690 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.053365e-02 | 1.688 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.053365e-02 | 1.688 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.088760e-02 | 1.680 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.088760e-02 | 1.680 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.113301e-02 | 1.675 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.159110e-02 | 1.666 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.204408e-02 | 1.657 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.205217e-02 | 1.657 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.219949e-02 | 1.654 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.219949e-02 | 1.654 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.237621e-02 | 1.650 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.268716e-02 | 1.644 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.406752e-02 | 1.619 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.406752e-02 | 1.619 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.459320e-02 | 1.609 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.521853e-02 | 1.598 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 2.527953e-02 | 1.597 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.766975e-02 | 1.558 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.766975e-02 | 1.558 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.775974e-02 | 1.557 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.775974e-02 | 1.557 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.793925e-02 | 1.554 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.793925e-02 | 1.554 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.793925e-02 | 1.554 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.793925e-02 | 1.554 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.793925e-02 | 1.554 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.807239e-02 | 1.552 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.807239e-02 | 1.552 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 2.807239e-02 | 1.552 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.897048e-02 | 1.538 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.971400e-02 | 1.527 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.974054e-02 | 1.527 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.974054e-02 | 1.527 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.038479e-02 | 1.517 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 3.038479e-02 | 1.517 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.074778e-02 | 1.512 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.181802e-02 | 1.497 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.230342e-02 | 1.491 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 3.245064e-02 | 1.489 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.333638e-02 | 1.477 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.333638e-02 | 1.477 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.333638e-02 | 1.477 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.333638e-02 | 1.477 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.333638e-02 | 1.477 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.333638e-02 | 1.477 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.416763e-02 | 1.466 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.418686e-02 | 1.466 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.441138e-02 | 1.463 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.473321e-02 | 1.459 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.516911e-02 | 1.454 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.516911e-02 | 1.454 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.627076e-02 | 1.440 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.701459e-02 | 1.432 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.720607e-02 | 1.429 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.720607e-02 | 1.429 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.922228e-02 | 1.406 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.043233e-02 | 1.393 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 4.043233e-02 | 1.393 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 4.078044e-02 | 1.390 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.092625e-02 | 1.388 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.113248e-02 | 1.386 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 4.136606e-02 | 1.383 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 4.225086e-02 | 1.374 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.225086e-02 | 1.374 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.281762e-02 | 1.368 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.281762e-02 | 1.368 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.358953e-02 | 1.361 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 4.404357e-02 | 1.356 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.640497e-02 | 1.333 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.641608e-02 | 1.333 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.695874e-02 | 1.328 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.785021e-02 | 1.320 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.785451e-02 | 1.320 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.857823e-02 | 1.314 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.857823e-02 | 1.314 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.998156e-02 | 1.301 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.074340e-02 | 1.295 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.117089e-02 | 1.291 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.194320e-02 | 1.284 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.374615e-02 | 1.270 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 5.374615e-02 | 1.270 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 5.374615e-02 | 1.270 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.554156e-02 | 1.255 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.554156e-02 | 1.255 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.554156e-02 | 1.255 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.598784e-02 | 1.252 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.654283e-02 | 1.248 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.665787e-02 | 1.247 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.672809e-02 | 1.246 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.672809e-02 | 1.246 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.672809e-02 | 1.246 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.672809e-02 | 1.246 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 5.672809e-02 | 1.246 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.672809e-02 | 1.246 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.022043e-01 | 0.991 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.022043e-01 | 0.991 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.022043e-01 | 0.991 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.022043e-01 | 0.991 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.022175e-01 | 0.990 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.022175e-01 | 0.990 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 7.480933e-02 | 1.126 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.509195e-02 | 1.022 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 9.509195e-02 | 1.022 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.001243e-02 | 1.222 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.664873e-02 | 1.176 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.059867e-01 | 0.975 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.059867e-01 | 0.975 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.364904e-02 | 1.133 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.100609e-02 | 1.091 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.759694e-02 | 1.170 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 9.675542e-02 | 1.014 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.675542e-02 | 1.014 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.333589e-02 | 1.135 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.051277e-01 | 0.978 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.051277e-01 | 0.978 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.051277e-01 | 0.978 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.051277e-01 | 0.978 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.138168e-01 | 0.944 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.138168e-01 | 0.944 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 8.005469e-02 | 1.097 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 6.941758e-02 | 1.159 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.089581e-01 | 0.963 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.153055e-01 | 0.938 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 7.333589e-02 | 1.135 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.836809e-02 | 1.106 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.468952e-02 | 1.072 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.933198e-02 | 1.101 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.985799e-02 | 1.156 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.302740e-02 | 1.200 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.664873e-02 | 1.176 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 6.505780e-02 | 1.187 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 9.103885e-02 | 1.041 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.381260e-02 | 1.132 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.844639e-02 | 1.105 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 7.007504e-02 | 1.154 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.544911e-02 | 1.068 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 7.007504e-02 | 1.154 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.146866e-01 | 0.940 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.022043e-01 | 0.991 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.022175e-01 | 0.990 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.001243e-02 | 1.222 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.819985e-02 | 1.166 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.059867e-01 | 0.975 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.058179e-01 | 0.975 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.333589e-02 | 1.135 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.933198e-02 | 1.101 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.577910e-02 | 1.067 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.485724e-02 | 1.126 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 8.100609e-02 | 1.091 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 8.100609e-02 | 1.091 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 8.568458e-02 | 1.067 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 1.059867e-01 | 0.975 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.546630e-02 | 1.122 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.110911e-02 | 1.214 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 1.058179e-01 | 0.975 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 9.509195e-02 | 1.022 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.116761e-01 | 0.952 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.001243e-02 | 1.222 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.818344e-02 | 1.008 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.093174e-01 | 0.961 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.664873e-02 | 1.176 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.155264e-01 | 0.937 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.739217e-02 | 1.111 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.022447e-02 | 1.154 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.211751e-02 | 1.207 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 1.058179e-01 | 0.975 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.505780e-02 | 1.187 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.100609e-02 | 1.091 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.066026e-01 | 0.972 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 6.110911e-02 | 1.214 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 8.308367e-02 | 1.080 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.558219e-02 | 1.068 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 7.364904e-02 | 1.133 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 1.051277e-01 | 0.978 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.933198e-02 | 1.101 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.865019e-02 | 1.163 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.480933e-02 | 1.126 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 7.485724e-02 | 1.126 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.308367e-02 | 1.080 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 6.754238e-02 | 1.170 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 1.059867e-01 | 0.975 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.089581e-01 | 0.963 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.051277e-01 | 0.978 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.985799e-02 | 1.156 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.100635e-01 | 0.958 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.562485e-02 | 1.121 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 9.208284e-02 | 1.036 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.675542e-02 | 1.014 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.185978e-02 | 1.037 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.173427e-01 | 0.931 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.195342e-01 | 0.923 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.195342e-01 | 0.923 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.195342e-01 | 0.923 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.204964e-01 | 0.919 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.228107e-01 | 0.911 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.228107e-01 | 0.911 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 1.230603e-01 | 0.910 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 1.281745e-01 | 0.892 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.291284e-01 | 0.889 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.320966e-01 | 0.879 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.338304e-01 | 0.873 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.350071e-01 | 0.870 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.352905e-01 | 0.869 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.360697e-01 | 0.866 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 1.375071e-01 | 0.862 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.375071e-01 | 0.862 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.375071e-01 | 0.862 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 1.375071e-01 | 0.862 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.375071e-01 | 0.862 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.375071e-01 | 0.862 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.375071e-01 | 0.862 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.375071e-01 | 0.862 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.375071e-01 | 0.862 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.402913e-01 | 0.853 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.408420e-01 | 0.851 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 1.413117e-01 | 0.850 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 1.413117e-01 | 0.850 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.413117e-01 | 0.850 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.413117e-01 | 0.850 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 1.413117e-01 | 0.850 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.416611e-01 | 0.849 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.456789e-01 | 0.837 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.493241e-01 | 0.826 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.493241e-01 | 0.826 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 1.493241e-01 | 0.826 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 1.493241e-01 | 0.826 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 1.493241e-01 | 0.826 | 0 | 0 |
| Defective SERPING1 causes hereditary angioedema | R-HSA-9657689 | 1.493241e-01 | 0.826 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 1.493241e-01 | 0.826 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 1.514904e-01 | 0.820 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.524824e-01 | 0.817 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.524824e-01 | 0.817 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 1.538605e-01 | 0.813 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 1.538605e-01 | 0.813 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.538605e-01 | 0.813 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.560198e-01 | 0.807 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.560198e-01 | 0.807 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.560198e-01 | 0.807 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.560198e-01 | 0.807 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.560198e-01 | 0.807 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.560198e-01 | 0.807 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 1.560198e-01 | 0.807 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.615702e-01 | 0.792 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.615702e-01 | 0.792 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.615702e-01 | 0.792 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 1.622020e-01 | 0.790 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.667425e-01 | 0.778 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 1.667425e-01 | 0.778 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.667425e-01 | 0.778 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.667425e-01 | 0.778 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.696733e-01 | 0.770 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.749664e-01 | 0.757 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.749664e-01 | 0.757 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.749664e-01 | 0.757 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.785403e-01 | 0.748 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.785403e-01 | 0.748 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.801114e-01 | 0.744 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.805613e-01 | 0.743 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.807228e-01 | 0.743 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 1.824231e-01 | 0.739 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 1.824231e-01 | 0.739 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.875769e-01 | 0.727 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.931663e-01 | 0.714 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 1.931663e-01 | 0.714 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 1.933796e-01 | 0.714 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.939736e-01 | 0.712 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 1.939736e-01 | 0.712 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 1.939736e-01 | 0.712 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 1.939736e-01 | 0.712 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.939736e-01 | 0.712 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.939736e-01 | 0.712 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.939736e-01 | 0.712 | 0 | 0 |
| Defective factor XII causes hereditary angioedema | R-HSA-9657688 | 1.939736e-01 | 0.712 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.939736e-01 | 0.712 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.942505e-01 | 0.712 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.942505e-01 | 0.712 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.942505e-01 | 0.712 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.942505e-01 | 0.712 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.942505e-01 | 0.712 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 1.967745e-01 | 0.706 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.973481e-01 | 0.705 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.976791e-01 | 0.704 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.040043e-01 | 0.690 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.041008e-01 | 0.690 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.041008e-01 | 0.690 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.041008e-01 | 0.690 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.070725e-01 | 0.684 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.070725e-01 | 0.684 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.070725e-01 | 0.684 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.097813e-01 | 0.678 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 2.137846e-01 | 0.670 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 2.137846e-01 | 0.670 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 2.209745e-01 | 0.656 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.241515e-01 | 0.649 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.252431e-01 | 0.647 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.334896e-01 | 0.632 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.334896e-01 | 0.632 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 2.334896e-01 | 0.632 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.334896e-01 | 0.632 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.334896e-01 | 0.632 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 2.334896e-01 | 0.632 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.334896e-01 | 0.632 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.334896e-01 | 0.632 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.350565e-01 | 0.629 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.350565e-01 | 0.629 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.350565e-01 | 0.629 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.350565e-01 | 0.629 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.350565e-01 | 0.629 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.350565e-01 | 0.629 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.362821e-01 | 0.627 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.362821e-01 | 0.627 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.362821e-01 | 0.627 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 2.362821e-01 | 0.627 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.362821e-01 | 0.627 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 2.362821e-01 | 0.627 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.376690e-01 | 0.624 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.379002e-01 | 0.624 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.435927e-01 | 0.613 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.472651e-01 | 0.607 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.492901e-01 | 0.603 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 2.492901e-01 | 0.603 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.494486e-01 | 0.603 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.494486e-01 | 0.603 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.494486e-01 | 0.603 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.526661e-01 | 0.597 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.532937e-01 | 0.596 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.532937e-01 | 0.596 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 2.532937e-01 | 0.596 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 2.548343e-01 | 0.594 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.573405e-01 | 0.589 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 2.634066e-01 | 0.579 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.636478e-01 | 0.579 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.636478e-01 | 0.579 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.649046e-01 | 0.577 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 2.731323e-01 | 0.564 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.731323e-01 | 0.564 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.731323e-01 | 0.564 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.731323e-01 | 0.564 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 2.731323e-01 | 0.564 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 2.731323e-01 | 0.564 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 2.731323e-01 | 0.564 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.731323e-01 | 0.564 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 2.741202e-01 | 0.562 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.750628e-01 | 0.561 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.763723e-01 | 0.559 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.763723e-01 | 0.559 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.763723e-01 | 0.559 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.763723e-01 | 0.559 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.763723e-01 | 0.559 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 2.773275e-01 | 0.557 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.800196e-01 | 0.553 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.832242e-01 | 0.548 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.834115e-01 | 0.548 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.834115e-01 | 0.548 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.847341e-01 | 0.546 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.847341e-01 | 0.546 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.872064e-01 | 0.542 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 2.926313e-01 | 0.534 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.929475e-01 | 0.533 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 2.929475e-01 | 0.533 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.072075e-01 | 0.513 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 3.072075e-01 | 0.513 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.072075e-01 | 0.513 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.078915e-01 | 0.512 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 3.109040e-01 | 0.507 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.126870e-01 | 0.505 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 3.126870e-01 | 0.505 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.126870e-01 | 0.505 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 3.134150e-01 | 0.504 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 3.134150e-01 | 0.504 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.140168e-01 | 0.503 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.143603e-01 | 0.503 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 3.143603e-01 | 0.503 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 3.143603e-01 | 0.503 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 3.143603e-01 | 0.503 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 3.143603e-01 | 0.503 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.143603e-01 | 0.503 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 3.143603e-01 | 0.503 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 3.143603e-01 | 0.503 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 3.143603e-01 | 0.503 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 3.143603e-01 | 0.503 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 3.143603e-01 | 0.503 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.143603e-01 | 0.503 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.163940e-01 | 0.500 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 3.195727e-01 | 0.495 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.202322e-01 | 0.495 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.206830e-01 | 0.494 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 3.206830e-01 | 0.494 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.206830e-01 | 0.494 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.223298e-01 | 0.492 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 3.241984e-01 | 0.489 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 3.268571e-01 | 0.486 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.302354e-01 | 0.481 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.323043e-01 | 0.478 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.364136e-01 | 0.473 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 3.364136e-01 | 0.473 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.390581e-01 | 0.470 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 3.503563e-01 | 0.455 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.503563e-01 | 0.455 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.503563e-01 | 0.455 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.503563e-01 | 0.455 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.503563e-01 | 0.455 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.503563e-01 | 0.455 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.503563e-01 | 0.455 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.503563e-01 | 0.455 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.503563e-01 | 0.455 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.503563e-01 | 0.455 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.503563e-01 | 0.455 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 3.503563e-01 | 0.455 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.510006e-01 | 0.455 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.510006e-01 | 0.455 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 3.517579e-01 | 0.454 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.517579e-01 | 0.454 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.517579e-01 | 0.454 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.517579e-01 | 0.454 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 3.517579e-01 | 0.454 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 3.517579e-01 | 0.454 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 3.517579e-01 | 0.454 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.517579e-01 | 0.454 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 3.569351e-01 | 0.447 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.621413e-01 | 0.441 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.655503e-01 | 0.437 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.710110e-01 | 0.431 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.710110e-01 | 0.431 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 3.710110e-01 | 0.431 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.710110e-01 | 0.431 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.710110e-01 | 0.431 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 3.710110e-01 | 0.431 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.710110e-01 | 0.431 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 3.736280e-01 | 0.428 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.736280e-01 | 0.428 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.736280e-01 | 0.428 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.736280e-01 | 0.428 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 3.771872e-01 | 0.423 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.795286e-01 | 0.421 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 3.800442e-01 | 0.420 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.844645e-01 | 0.415 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.844645e-01 | 0.415 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.844645e-01 | 0.415 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 3.844645e-01 | 0.415 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.844645e-01 | 0.415 | 0 | 0 |
| Metabolism of ingested MeSeO2H into MeSeH | R-HSA-5263617 | 3.844645e-01 | 0.415 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.844645e-01 | 0.415 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.844645e-01 | 0.415 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.844645e-01 | 0.415 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.844645e-01 | 0.415 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.844645e-01 | 0.415 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 3.844645e-01 | 0.415 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.844645e-01 | 0.415 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.862669e-01 | 0.413 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.900310e-01 | 0.409 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.900310e-01 | 0.409 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.900310e-01 | 0.409 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.900310e-01 | 0.409 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.900310e-01 | 0.409 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.900310e-01 | 0.409 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 3.900310e-01 | 0.409 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.900780e-01 | 0.409 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.056905e-01 | 0.392 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.087894e-01 | 0.389 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 4.087894e-01 | 0.389 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.087959e-01 | 0.388 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.087959e-01 | 0.388 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.087959e-01 | 0.388 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.087959e-01 | 0.388 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.111312e-01 | 0.386 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.139647e-01 | 0.383 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 4.167839e-01 | 0.380 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 4.167839e-01 | 0.380 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.167839e-01 | 0.380 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.167839e-01 | 0.380 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 4.167839e-01 | 0.380 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.167839e-01 | 0.380 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 4.167839e-01 | 0.380 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.167839e-01 | 0.380 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.167839e-01 | 0.380 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.171485e-01 | 0.380 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.201710e-01 | 0.377 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.265691e-01 | 0.370 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.265691e-01 | 0.370 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.272612e-01 | 0.369 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 4.272612e-01 | 0.369 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.272612e-01 | 0.369 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.272612e-01 | 0.369 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.320766e-01 | 0.364 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 4.342378e-01 | 0.362 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.343695e-01 | 0.362 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.371292e-01 | 0.359 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.424922e-01 | 0.354 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 4.426443e-01 | 0.354 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.454249e-01 | 0.351 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.454249e-01 | 0.351 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 4.454249e-01 | 0.351 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 4.454249e-01 | 0.351 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 4.454249e-01 | 0.351 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.454249e-01 | 0.351 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.454249e-01 | 0.351 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 4.454249e-01 | 0.351 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 4.474081e-01 | 0.349 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 4.474081e-01 | 0.349 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.474081e-01 | 0.349 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.474081e-01 | 0.349 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.474081e-01 | 0.349 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.474081e-01 | 0.349 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.474081e-01 | 0.349 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 4.474081e-01 | 0.349 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 4.474081e-01 | 0.349 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.474081e-01 | 0.349 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 4.474081e-01 | 0.349 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.474081e-01 | 0.349 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.506593e-01 | 0.346 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.506593e-01 | 0.346 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.511040e-01 | 0.346 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 4.511040e-01 | 0.346 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.511040e-01 | 0.346 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 4.511040e-01 | 0.346 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.528612e-01 | 0.344 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 4.631777e-01 | 0.334 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.632620e-01 | 0.334 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 4.632620e-01 | 0.334 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.632620e-01 | 0.334 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.646065e-01 | 0.333 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.649345e-01 | 0.333 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.649345e-01 | 0.333 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.720823e-01 | 0.326 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.720823e-01 | 0.326 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.720823e-01 | 0.326 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.764261e-01 | 0.322 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 4.764261e-01 | 0.322 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 4.764261e-01 | 0.322 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.764261e-01 | 0.322 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.764261e-01 | 0.322 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.764261e-01 | 0.322 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.764261e-01 | 0.322 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.764261e-01 | 0.322 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.764261e-01 | 0.322 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.764261e-01 | 0.322 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.786093e-01 | 0.320 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 4.807566e-01 | 0.318 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.807566e-01 | 0.318 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.807566e-01 | 0.318 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 4.838637e-01 | 0.315 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.857773e-01 | 0.314 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.857773e-01 | 0.314 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 4.874955e-01 | 0.312 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.921182e-01 | 0.308 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.921182e-01 | 0.308 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 4.978956e-01 | 0.303 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 4.978956e-01 | 0.303 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 4.978956e-01 | 0.303 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.978956e-01 | 0.303 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.978956e-01 | 0.303 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.978956e-01 | 0.303 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.978956e-01 | 0.303 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 4.978956e-01 | 0.303 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 4.988983e-01 | 0.302 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 4.988983e-01 | 0.302 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 5.039219e-01 | 0.298 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.039219e-01 | 0.298 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.039219e-01 | 0.298 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 5.039219e-01 | 0.298 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.039219e-01 | 0.298 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.039219e-01 | 0.298 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 5.039219e-01 | 0.298 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 5.039219e-01 | 0.298 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.039219e-01 | 0.298 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.039219e-01 | 0.298 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 5.054518e-01 | 0.296 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 5.054518e-01 | 0.296 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.054518e-01 | 0.296 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.101903e-01 | 0.292 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.101903e-01 | 0.292 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.102018e-01 | 0.292 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.146681e-01 | 0.288 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.146681e-01 | 0.288 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.146681e-01 | 0.288 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.213654e-01 | 0.283 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.213654e-01 | 0.283 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.299754e-01 | 0.276 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.299754e-01 | 0.276 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.299754e-01 | 0.276 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.299754e-01 | 0.276 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.299754e-01 | 0.276 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.299754e-01 | 0.276 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 5.299754e-01 | 0.276 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.299754e-01 | 0.276 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.299754e-01 | 0.276 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 5.299754e-01 | 0.276 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 5.299754e-01 | 0.276 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.299754e-01 | 0.276 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 5.299754e-01 | 0.276 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 5.310653e-01 | 0.275 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 5.310653e-01 | 0.275 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 5.315600e-01 | 0.274 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.345964e-01 | 0.272 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 5.392743e-01 | 0.268 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.443199e-01 | 0.264 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.452730e-01 | 0.263 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.470803e-01 | 0.262 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.470803e-01 | 0.262 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.470803e-01 | 0.262 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.470803e-01 | 0.262 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.470803e-01 | 0.262 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.470803e-01 | 0.262 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 5.470803e-01 | 0.262 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 5.546620e-01 | 0.256 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.546620e-01 | 0.256 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.546620e-01 | 0.256 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.546620e-01 | 0.256 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.546620e-01 | 0.256 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 5.546620e-01 | 0.256 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 5.546620e-01 | 0.256 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.546620e-01 | 0.256 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 5.551791e-01 | 0.256 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.568754e-01 | 0.254 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.600216e-01 | 0.252 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.627082e-01 | 0.250 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.627082e-01 | 0.250 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 5.627082e-01 | 0.250 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.660631e-01 | 0.247 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.717035e-01 | 0.243 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.779453e-01 | 0.238 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.779453e-01 | 0.238 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.779453e-01 | 0.238 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.779453e-01 | 0.238 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.779453e-01 | 0.238 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.779453e-01 | 0.238 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.779453e-01 | 0.238 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.780535e-01 | 0.238 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.780535e-01 | 0.238 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.780535e-01 | 0.238 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.780535e-01 | 0.238 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.780535e-01 | 0.238 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.780535e-01 | 0.238 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.780535e-01 | 0.238 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.780535e-01 | 0.238 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.780535e-01 | 0.238 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.780535e-01 | 0.238 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.780535e-01 | 0.238 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 5.780535e-01 | 0.238 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.780535e-01 | 0.238 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.780535e-01 | 0.238 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 5.780535e-01 | 0.238 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.780535e-01 | 0.238 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.786687e-01 | 0.238 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.810061e-01 | 0.236 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.813521e-01 | 0.236 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 5.927897e-01 | 0.227 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.927897e-01 | 0.227 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.002177e-01 | 0.222 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.002177e-01 | 0.222 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.002177e-01 | 0.222 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.002177e-01 | 0.222 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.029605e-01 | 0.220 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.049548e-01 | 0.218 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.212188e-01 | 0.207 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.212188e-01 | 0.207 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 6.212188e-01 | 0.207 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 6.212188e-01 | 0.207 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.212188e-01 | 0.207 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.212188e-01 | 0.207 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.212981e-01 | 0.207 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.212981e-01 | 0.207 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.212981e-01 | 0.207 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.212981e-01 | 0.207 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.212981e-01 | 0.207 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.276585e-01 | 0.202 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.332319e-01 | 0.198 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.344407e-01 | 0.198 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.349640e-01 | 0.197 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.349640e-01 | 0.197 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 6.349640e-01 | 0.197 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.411180e-01 | 0.193 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.411180e-01 | 0.193 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.411180e-01 | 0.193 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.411180e-01 | 0.193 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.411180e-01 | 0.193 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.411180e-01 | 0.193 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.411180e-01 | 0.193 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.482404e-01 | 0.188 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.482404e-01 | 0.188 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.506927e-01 | 0.187 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 6.512933e-01 | 0.186 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.539379e-01 | 0.184 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.549818e-01 | 0.184 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.549818e-01 | 0.184 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.595322e-01 | 0.181 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.598699e-01 | 0.181 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 6.599729e-01 | 0.180 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 6.599729e-01 | 0.180 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.599729e-01 | 0.180 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.599729e-01 | 0.180 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.599729e-01 | 0.180 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.599729e-01 | 0.180 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.599729e-01 | 0.180 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.599729e-01 | 0.180 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 6.599729e-01 | 0.180 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 6.599729e-01 | 0.180 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.599729e-01 | 0.180 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.599729e-01 | 0.180 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.599729e-01 | 0.180 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 6.599729e-01 | 0.180 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.611306e-01 | 0.180 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.611306e-01 | 0.180 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.646807e-01 | 0.177 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.703118e-01 | 0.174 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.703118e-01 | 0.174 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.736386e-01 | 0.172 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.778383e-01 | 0.169 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.778383e-01 | 0.169 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 6.778383e-01 | 0.169 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.778383e-01 | 0.169 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.778383e-01 | 0.169 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.778383e-01 | 0.169 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.801244e-01 | 0.167 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 6.803972e-01 | 0.167 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 6.803972e-01 | 0.167 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 6.902517e-01 | 0.161 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 6.902517e-01 | 0.161 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 6.947661e-01 | 0.158 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.947661e-01 | 0.158 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.947661e-01 | 0.158 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.947661e-01 | 0.158 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 6.947661e-01 | 0.158 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.975264e-01 | 0.156 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.978431e-01 | 0.156 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.081077e-01 | 0.150 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 7.092713e-01 | 0.149 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.108053e-01 | 0.148 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.108053e-01 | 0.148 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.108053e-01 | 0.148 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.108053e-01 | 0.148 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.108053e-01 | 0.148 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.108053e-01 | 0.148 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.199470e-01 | 0.143 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.199470e-01 | 0.143 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.199470e-01 | 0.143 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.199470e-01 | 0.143 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.199470e-01 | 0.143 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.260027e-01 | 0.139 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.260027e-01 | 0.139 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.260027e-01 | 0.139 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 7.260027e-01 | 0.139 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.376052e-01 | 0.132 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 7.404023e-01 | 0.131 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.404023e-01 | 0.131 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.404023e-01 | 0.131 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.404023e-01 | 0.131 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.404023e-01 | 0.131 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.404023e-01 | 0.131 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 7.404023e-01 | 0.131 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.404023e-01 | 0.131 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.404023e-01 | 0.131 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.409505e-01 | 0.130 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.409505e-01 | 0.130 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.409505e-01 | 0.130 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.468681e-01 | 0.127 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.509378e-01 | 0.124 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.523596e-01 | 0.124 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.540460e-01 | 0.123 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.540460e-01 | 0.123 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.540460e-01 | 0.123 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.540460e-01 | 0.123 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.540460e-01 | 0.123 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.540460e-01 | 0.123 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 7.540460e-01 | 0.123 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.605918e-01 | 0.119 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 7.605918e-01 | 0.119 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.669734e-01 | 0.115 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 7.669734e-01 | 0.115 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.669734e-01 | 0.115 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.669734e-01 | 0.115 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.669734e-01 | 0.115 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.669734e-01 | 0.115 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.699199e-01 | 0.114 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.789297e-01 | 0.109 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.789297e-01 | 0.109 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.792220e-01 | 0.108 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.792220e-01 | 0.108 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.792220e-01 | 0.108 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.792220e-01 | 0.108 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 7.792220e-01 | 0.108 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 7.828123e-01 | 0.106 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.876289e-01 | 0.104 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.876289e-01 | 0.104 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.876289e-01 | 0.104 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.876289e-01 | 0.104 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 7.908276e-01 | 0.102 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.908276e-01 | 0.102 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.908276e-01 | 0.102 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.908276e-01 | 0.102 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.908276e-01 | 0.102 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 7.910536e-01 | 0.102 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 7.996777e-01 | 0.097 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.018237e-01 | 0.096 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.018237e-01 | 0.096 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.018237e-01 | 0.096 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 8.018237e-01 | 0.096 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.018237e-01 | 0.096 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.018237e-01 | 0.096 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.029404e-01 | 0.095 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.041263e-01 | 0.095 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.109271e-01 | 0.091 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.122424e-01 | 0.090 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.122424e-01 | 0.090 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.122424e-01 | 0.090 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.122424e-01 | 0.090 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 8.122424e-01 | 0.090 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.122424e-01 | 0.090 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.194746e-01 | 0.086 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.221140e-01 | 0.085 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.221140e-01 | 0.085 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.221140e-01 | 0.085 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.221140e-01 | 0.085 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.221140e-01 | 0.085 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 8.238268e-01 | 0.084 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.267373e-01 | 0.083 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.277459e-01 | 0.082 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.314671e-01 | 0.080 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.314671e-01 | 0.080 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.314671e-01 | 0.080 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.314671e-01 | 0.080 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.361443e-01 | 0.078 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.403289e-01 | 0.076 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.403289e-01 | 0.076 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.403289e-01 | 0.076 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.404783e-01 | 0.075 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.418501e-01 | 0.075 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.487254e-01 | 0.071 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.487254e-01 | 0.071 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 8.487254e-01 | 0.071 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.566807e-01 | 0.067 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.576633e-01 | 0.067 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.650349e-01 | 0.063 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.678633e-01 | 0.062 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.713596e-01 | 0.060 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.713596e-01 | 0.060 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.759679e-01 | 0.058 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.781259e-01 | 0.056 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.811228e-01 | 0.055 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.845367e-01 | 0.053 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.845367e-01 | 0.053 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.860791e-01 | 0.053 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.906106e-01 | 0.050 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.906106e-01 | 0.050 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.906106e-01 | 0.050 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.906106e-01 | 0.050 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.908433e-01 | 0.050 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.918154e-01 | 0.050 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.918154e-01 | 0.050 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 8.920632e-01 | 0.050 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.963653e-01 | 0.048 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.963653e-01 | 0.048 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 8.963653e-01 | 0.048 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 8.978325e-01 | 0.047 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.998213e-01 | 0.046 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.998213e-01 | 0.046 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.998213e-01 | 0.046 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.010828e-01 | 0.045 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.018177e-01 | 0.045 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.018177e-01 | 0.045 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.018177e-01 | 0.045 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.038987e-01 | 0.044 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.040477e-01 | 0.044 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.069835e-01 | 0.042 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.069835e-01 | 0.042 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.093894e-01 | 0.041 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.118778e-01 | 0.040 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.118778e-01 | 0.040 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.120052e-01 | 0.040 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.121159e-01 | 0.040 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.165148e-01 | 0.038 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.209081e-01 | 0.036 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.209081e-01 | 0.036 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.209081e-01 | 0.036 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 9.250705e-01 | 0.034 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.250705e-01 | 0.034 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.274741e-01 | 0.033 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.290141e-01 | 0.032 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.290141e-01 | 0.032 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.292731e-01 | 0.032 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.292731e-01 | 0.032 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.362901e-01 | 0.029 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.391903e-01 | 0.027 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.396438e-01 | 0.027 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.396438e-01 | 0.027 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.425546e-01 | 0.026 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.451666e-01 | 0.024 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.457721e-01 | 0.024 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.481383e-01 | 0.023 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.486833e-01 | 0.023 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.513853e-01 | 0.022 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.513853e-01 | 0.022 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.516480e-01 | 0.022 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.519838e-01 | 0.021 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.525786e-01 | 0.021 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.528734e-01 | 0.021 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.539451e-01 | 0.020 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.543809e-01 | 0.020 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.563703e-01 | 0.019 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.608447e-01 | 0.017 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.629070e-01 | 0.016 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.638221e-01 | 0.016 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.667498e-01 | 0.015 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.698437e-01 | 0.013 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.698437e-01 | 0.013 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.731915e-01 | 0.012 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.731915e-01 | 0.012 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.731915e-01 | 0.012 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.731915e-01 | 0.012 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.737136e-01 | 0.012 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.746040e-01 | 0.011 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.748935e-01 | 0.011 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.759423e-01 | 0.011 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.784111e-01 | 0.009 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.784111e-01 | 0.009 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.795489e-01 | 0.009 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.816009e-01 | 0.008 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.816480e-01 | 0.008 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.818311e-01 | 0.008 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.826154e-01 | 0.008 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.826154e-01 | 0.008 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.835318e-01 | 0.007 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.857097e-01 | 0.006 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.858383e-01 | 0.006 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.860017e-01 | 0.006 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.860017e-01 | 0.006 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.860017e-01 | 0.006 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.860017e-01 | 0.006 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.863027e-01 | 0.006 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.863766e-01 | 0.006 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.887290e-01 | 0.005 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.896378e-01 | 0.005 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.901152e-01 | 0.004 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.904200e-01 | 0.004 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.909254e-01 | 0.004 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.918576e-01 | 0.004 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.925597e-01 | 0.003 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.932346e-01 | 0.003 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.934059e-01 | 0.003 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.941185e-01 | 0.003 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.963902e-01 | 0.002 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.969324e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.969324e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.972479e-01 | 0.001 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.979021e-01 | 0.001 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.981073e-01 | 0.001 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.984092e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.985654e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.990022e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.996548e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.997615e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.997741e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.998061e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.998887e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.998970e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999002e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999617e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999642e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999658e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999805e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999814e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999835e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999899e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999935e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999984e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999985e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999992e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999998e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |